Page last updated: 2024-07-31 17:45:53

ifetroban

Description

ifetroban: thromboxane receptor antagonist; structure given in first source; a 7-oxabicyclo(2.2.1)heptane derivative [MeSH]

ifetroban : no description available [CHeBI]

Cross-References

ID SourceID
PubMed CID3037233
CHEMBL ID3301673
SCHEMBL ID28135
CHEBI ID188730
MeSH IDM0211381

Synonyms (28)

Synonym
bms 180,291
gtpl1987
3-[2-[[(1s,4r,5s,6r)-5-[4-(pentylcarbamoyl)-1,3-oxazol-2-yl]-7-oxabicyclo[2.2.1]heptan-6-yl]methyl]phenyl]propanoic acid
143443-90-7
bms180291
benzenepropanoic acid, 2-((3-(4-((pentylamino)carbonyl)-2-oxazolyl)-7-oxabicyclo(2.2.1)hept-2-yl)methyl)-, (1s-(exo,exo))-
ifetroban
bms-180291
ifetroban [usan:inn]
bms 180291-02
bms 180291
o-((1s,2r,3s,4r)-3-(4-(pentylcarbamoyl)-2-oxazolyl)-7-oxabicyclo(2.2.1)hept-2-yl)methyl)hydrocinnamic acid
bdbm50212318
CHEBI:188730
3-[2-[[(1s,2r,3s,4r)-3-[4-(pentylcarbamoyl)-1,3-oxazol-2-yl]-7-oxabicyclo[2.2.1]heptan-2-yl]methyl]phenyl]propanoic acid
unii-e833kt807k
e833kt807k ,
CHEMBL3301673
SCHEMBL28135
o-[[1s,2r,3s,4r)-3-[4-(pentylcarbamoyl)-2-oxazolyl]-7-oxabicyclo[2.2.1]hept-2-yl]methyl]hydrocinnamic acid
ifetroban [inn]
ifetroban [usan]
CS-0025381
HY-105218
DB12321
DTXSID40869931
Q5991162
AKOS040748563

Drug Classes (2)

ClassDescription
monocarboxylic acidAn oxoacid containing a single carboxy group.
benzenesAny benzenoid aromatic compound consisting of the benzene skeleton and its substituted derivatives.

Bioassays (17)

Assay IDTitleYearJournalArticle
AID540219Volume of distribution at steady state in monkey after iv administration2005Journal of pharmaceutical sciences, Jul, Volume: 94, Issue:7
ISSN: 0022-3549
Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure.
AID540214Clearance in rat after iv administration2005Journal of pharmaceutical sciences, Jul, Volume: 94, Issue:7
ISSN: 0022-3549
Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure.
AID540217Volume of distribution at steady state in dog after iv administration2005Journal of pharmaceutical sciences, Jul, Volume: 94, Issue:7
ISSN: 0022-3549
Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure.
AID540210Clearance in human after iv administration2008Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 36, Issue:7
ISSN: 1521-009X
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
AID540220Clearance in human after iv administration2005Journal of pharmaceutical sciences, Jul, Volume: 94, Issue:7
ISSN: 0022-3549
Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure.
AID540215Volume of distribution at steady state in rat after iv administration2005Journal of pharmaceutical sciences, Jul, Volume: 94, Issue:7
ISSN: 0022-3549
Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure.
AID540216Clearance in dog after iv administration2005Journal of pharmaceutical sciences, Jul, Volume: 94, Issue:7
ISSN: 0022-3549
Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure.
AID540213Half life in human after iv administration2008Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 36, Issue:7
ISSN: 1521-009X
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
AID540230Dose normalised AUC in rat after po administration2005Xenobiotica; the fate of foreign compounds in biological systems, Feb, Volume: 35, Issue:2
ISSN: 0049-8254
Comparative evaluation of oral systemic exposure of 56 xenobiotics in rat, dog, monkey and human.
AID540221Volume of distribution at steady state in human after iv administration2005Journal of pharmaceutical sciences, Jul, Volume: 94, Issue:7
ISSN: 0022-3549
Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure.
AID540209Volume of distribution at steady state in human after iv administration2008Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 36, Issue:7
ISSN: 1521-009X
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
AID540231Dose normalised AUC in dog after po administration2005Xenobiotica; the fate of foreign compounds in biological systems, Feb, Volume: 35, Issue:2
ISSN: 0049-8254
Comparative evaluation of oral systemic exposure of 56 xenobiotics in rat, dog, monkey and human.
AID540212Mean residence time in human after iv administration2008Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 36, Issue:7
ISSN: 1521-009X
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
AID540218Clearance in monkey after iv administration2005Journal of pharmaceutical sciences, Jul, Volume: 94, Issue:7
ISSN: 0022-3549
Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure.
AID540232Dose normalised AUC in monkey after po administration2005Xenobiotica; the fate of foreign compounds in biological systems, Feb, Volume: 35, Issue:2
ISSN: 0049-8254
Comparative evaluation of oral systemic exposure of 56 xenobiotics in rat, dog, monkey and human.
AID540233Dose normalised AUC in human after po administration2005Xenobiotica; the fate of foreign compounds in biological systems, Feb, Volume: 35, Issue:2
ISSN: 0049-8254
Comparative evaluation of oral systemic exposure of 56 xenobiotics in rat, dog, monkey and human.
AID1346422Human TP receptor (Prostanoid receptors)1993The Journal of pharmacology and experimental therapeutics, Feb, Volume: 264, Issue:2
ISSN: 0022-3565
Pharmacological profile of BMS 180,291: a potent, long-acting, orally active thromboxane A2/prostaglandin endoperoxide receptor antagonist.

Research

Studies (44)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's29 (65.91)18.2507
2000's11 (25.00)29.6817
2010's3 (6.82)24.3611
2020's1 (2.27)2.80

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials3 (6.67%)5.53%
Reviews2 (4.44%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other40 (88.89%)84.16%
SubstanceStudiesClassesRolesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
dihydro-3-coumaric acidmonocarboxylic acidEscherichia coli metabolite;
human xenobiotic metabolite
00low000000
3-phenylpropionic acidbenzenes;
monocarboxylic acid
antifungal agent;
human metabolite;
plant metabolite
00low000000
2-(3-pyridine)acetic acidmonocarboxylic acid;
pyridines
human xenobiotic metabolite00low000000
gamma-aminobutyric acidamino acid zwitterion;
gamma-amino acid;
monocarboxylic acid
human metabolite;
neurotransmitter;
Saccharomyces cerevisiae metabolite;
signalling molecule
00low000000
4-hydroxyphenylacetic acidmonocarboxylic acid;
phenols
fungal metabolite;
human metabolite;
mouse metabolite;
plant metabolite
00low000000
acetic acidmonocarboxylic acidantimicrobial food preservative;
Daphnia magna metabolite;
food acidity regulator;
protic solvent
00low000000
formic acidmonocarboxylic acidantibacterial agent;
astringent;
metabolite;
protic solvent;
solvent
00low000000
aminooxyacetic acidamino acid;
hydroxylamines;
monocarboxylic acid
anticonvulsant;
EC 2.6.1.19 (4-aminobutyrate--2-oxoglutarate transaminase) inhibitor;
EC 4.2.1.22 (cystathionine beta-synthase) inhibitor;
nootropic agent
00low000000
4-oxo-4-(3-pyridyl)butanoic acidaromatic ketone;
monocarboxylic acid;
pyridines
00low000000
gamma-guanidinobutyric acidguanidines;
monocarboxylic acid;
zwitterion
fungal metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
00low000000
1-aminocyclopropane-1-carboxylic acidamino acid zwitterion;
monocarboxylic acid;
non-proteinogenic alpha-amino acid
ethylene releasers;
plant metabolite
00low000000
phosphonoacetic acidmonocarboxylic acid;
phosphonic acids
antiviral agent;
EC 2.7.7.7 (DNA-directed DNA polymerase) inhibitor
00low000000
5,6-dihydroorotatemonocarboxylic acid;
N-acylurea;
pyrimidinemonocarboxylic acid;
secondary amide
00low000000
hydantoin-5-propionic acidimidazolidine-2,4-dione;
monocarboxylic acid
metabolite;
mouse metabolite
00low000000
indoleacetic acidindole-3-acetic acids;
monocarboxylic acid
auxin;
human metabolite;
mouse metabolite;
plant hormone;
plant metabolite
00low000000
melilotic acidmonocarboxylic acid;
phenols
bacterial xenobiotic metabolite;
fungal xenobiotic metabolite;
human xenobiotic metabolite;
plant metabolite
00low000000
phenylacetic acidbenzenes;
monocarboxylic acid;
phenylacetic acids
allergen;
Aspergillus metabolite;
auxin;
EC 6.4.1.1 (pyruvate carboxylase) inhibitor;
Escherichia coli metabolite;
human metabolite;
plant growth retardant;
plant metabolite;
Saccharomyces cerevisiae metabolite;
toxin
00low000000
phosphoenolpyruvatecarboxyalkyl phosphate;
monocarboxylic acid
fundamental metabolite00low000000
4-(2,4-dichlorophenoxy)butyric acidaromatic ether;
monocarboxylic acid;
organochlorine compound
agrochemical;
phenoxy herbicide;
synthetic auxin
00low000000
homovanillic acidguaiacols;
monocarboxylic acid
human metabolite;
mouse metabolite
00low000000
acemetacincarboxylic ester;
indol-3-yl carboxylic acid;
monocarboxylic acid;
monochlorobenzenes;
N-acylindole
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
prodrug
00low000000
alminoprofenamino acid;
monocarboxylic acid;
secondary amino compound;
substituted aniline
antipyretic;
antirheumatic drug;
cyclooxygenase 2 inhibitor;
EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor;
EC 3.1.1.4 (phospholipase A2) inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug
00low000000
alpha-methyl-m-tyrosinemonocarboxylic acid00low000000
amlexanoxmonocarboxylic acid;
pyridochromene
anti-allergic agent;
anti-ulcer drug;
non-steroidal anti-inflammatory drug
00low000000
aristolochic acid iaristolochic acids;
aromatic ether;
C-nitro compound;
cyclic acetal;
monocarboxylic acid;
organic heterotetracyclic compound
carcinogenic agent;
metabolite;
mutagen;
nephrotoxin;
toxin
00low000000
baclofenamino acid zwitterion;
gamma-amino acid;
monocarboxylic acid;
monochlorobenzenes;
primary amino compound
central nervous system depressant;
GABA agonist;
muscle relaxant
00low000000
bendazacindazoles;
monocarboxylic acid
non-steroidal anti-inflammatory drug;
radical scavenger
00low000000
metrizoatemonocarboxylic acidradioopaque medium00low000000
carbidopabenzenes;
monocarboxylic acid
00low000000
cetirizineether;
monocarboxylic acid;
monochlorobenzenes;
piperazines
anti-allergic agent;
environmental contaminant;
H1-receptor antagonist;
xenobiotic
00low000000
cetraxatebenzenes;
monocarboxylic acid
00low000000
chlorambucilaromatic amine;
monocarboxylic acid;
nitrogen mustard;
organochlorine compound;
tertiary amino compound
alkylating agent;
antineoplastic agent;
carcinogenic agent;
drug allergen;
immunosuppressive agent
00low000000
chrysanthemic acidcyclopropanes;
monocarboxylic acid
plant metabolite00low000000
ciprofibratecyclopropanes;
monocarboxylic acid;
organochlorine compound
antilipemic drug00low000000
clofibric acidaromatic ether;
monocarboxylic acid;
monochlorobenzenes
anticholesteremic drug;
antilipemic drug;
antineoplastic agent;
herbicide;
marine xenobiotic metabolite;
PPARalpha agonist
00low000000
diclofenacamino acid;
aromatic amine;
dichlorobenzene;
monocarboxylic acid;
secondary amino compound
antipyretic;
drug allergen;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
environmental contaminant;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
xenobiotic
00low000000
enoxacin1,8-naphthyridine derivative;
amino acid;
fluoroquinolone antibiotic;
monocarboxylic acid;
N-arylpiperazine;
quinolone antibiotic
antibacterial drug;
DNA synthesis inhibitor
00low000000
ethacrynic acidaromatic ether;
aromatic ketone;
dichlorobenzene;
monocarboxylic acid
EC 2.5.1.18 (glutathione transferase) inhibitor;
ion transport inhibitor;
loop diuretic
00low000000
etodolacmonocarboxylic acid;
organic heterotricyclic compound
antipyretic;
cyclooxygenase 2 inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug
00low000000
4-biphenylylacetic acidbiphenyls;
monocarboxylic acid
non-steroidal anti-inflammatory drug00low000000
fenoprofenmonocarboxylic acidantipyretic;
cyclooxygenase 1 inhibitor;
cyclooxygenase 2 inhibitor;
drug allergen;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug
00low000000
fleroxacindifluorobenzene;
fluoroquinolone antibiotic;
monocarboxylic acid;
N-alkylpiperazine;
quinolines
antibacterial drug;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
topoisomerase IV inhibitor
00low000000
flurbiprofenfluorobiphenyl;
monocarboxylic acid
antipyretic;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug
00low000000
ibuprofenmonocarboxylic acidantipyretic;
cyclooxygenase 1 inhibitor;
cyclooxygenase 2 inhibitor;
drug allergen;
environmental contaminant;
geroprotector;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
radical scavenger;
xenobiotic
00low000000
ici 204448monocarboxylic acid00low000000
indoprofengamma-lactam;
isoindoles;
monocarboxylic acid
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug
00low000000
iopanoic acidmonocarboxylic acid00low000000
ketorolacamino acid;
aromatic ketone;
monocarboxylic acid;
pyrrolizines;
racemate
analgesic;
cyclooxygenase 1 inhibitor;
cyclooxygenase 2 inhibitor;
non-steroidal anti-inflammatory drug
00low000000
loxoprofencyclopentanones;
monocarboxylic acid
antipyretic;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
prodrug
00low000000
meclofenoxatemonocarboxylic acid00low000000
sarkolysinmonocarboxylic acid00low000000
mesalamineamino acid;
aromatic amine;
monocarboxylic acid;
monohydroxybenzoic acid;
phenols
non-steroidal anti-inflammatory drug00low000000
3-Hydroxy-alpha-methyl-DL-tyrosinebenzenes;
monocarboxylic acid
00low000000
nalidixic acid1,8-naphthyridine derivative;
monocarboxylic acid;
quinolone antibiotic
antibacterial drug;
antimicrobial agent;
DNA synthesis inhibitor
00low000000
oxonic acid1,3,5-triazines;
monocarboxylic acid
00low000000
oxaprozin1,3-oxazoles;
monocarboxylic acid
analgesic;
non-steroidal anti-inflammatory drug
00low000000
oxyphencycliminemonocarboxylic acid00low000000
4-phenylbutyric acidmonocarboxylic acidantineoplastic agent;
apoptosis inducer;
EC 3.5.1.98 (histone deacetylase) inhibitor;
prodrug
00low000000
pipemidic acidamino acid;
monocarboxylic acid;
N-arylpiperazine;
pyridopyrimidine;
quinolone antibiotic
antibacterial drug;
DNA synthesis inhibitor
00low000000
piromidic acidmonocarboxylic acid;
pyridopyrimidine;
pyrrolidines;
quinolone antibiotic;
tertiary amino compound
antibacterial drug;
DNA synthesis inhibitor
00low000000
SU5402monocarboxylic acid;
oxindoles;
pyrroles
fibroblast growth factor receptor antagonist00low000000
suprofenaromatic ketone;
monocarboxylic acid;
thiophenes
antirheumatic drug;
drug allergen;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
peripheral nervous system drug
00low000000
suxibuzonehemisuccinate;
monocarboxylic acid;
pyrazolidines
antirheumatic drug;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
peripheral nervous system drug;
prodrug
00low000000
tiaprofenic acidaromatic ketone;
monocarboxylic acid;
thiophenes
drug allergen;
non-steroidal anti-inflammatory drug
00low000000
tolmetinaromatic ketone;
monocarboxylic acid;
pyrroles
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
non-steroidal anti-inflammatory drug
00low000000
tosufloxacin1,8-naphthyridine derivative;
amino acid;
aminopyrrolidine;
monocarboxylic acid;
organofluorine compound;
primary amino compound;
quinolone antibiotic;
tertiary amino compound
00low000000
tyropanoatebenzenes;
monocarboxylic acid
00low000000
zomepiracaromatic ketone;
monocarboxylic acid;
monochlorobenzenes;
pyrroles
cardiovascular drug;
non-steroidal anti-inflammatory drug
00low000000
trichloroacetic acidmonocarboxylic acid;
organochlorine compound
carcinogenic agent;
metabolite;
mouse metabolite
00low000000
dichloroacetic acidmonocarboxylic acid;
organochlorine compound
astringent;
marine metabolite
00low000000
bis(p-chlorophenyl)acetic acidmonocarboxylic acid;
monochlorobenzenes
00low000000
2-phenylbutyric acidbenzenes;
monocarboxylic acid
human xenobiotic metabolite00low000000
mecoproparomatic ether;
monocarboxylic acid;
monochlorobenzenes
00low000000
fenopropmonocarboxylic acidphenoxy herbicide00low000000
piperonylic acidaromatic carboxylic acid;
benzodioxoles;
monocarboxylic acid
antifungal agent;
EC 1.14.14.91 ( trans-cinnamate 4-monooxygenase) inhibitor;
plant metabolite;
vulnerary
00low000000
2-methyl-4-chlorophenoxy gamma-butyric acidaromatic ether;
monocarboxylic acid;
monochlorobenzenes
environmental contaminant;
phenoxy herbicide;
xenobiotic
00low000000
iophenoxic acidbenzenes;
monocarboxylic acid
00low000000
2-methylvaleric acidbranched-chain saturated fatty acid;
methyl-branched fatty acid;
monocarboxylic acid;
short-chain fatty acid
flavouring agent;
fragrance;
plant metabolite
00low000000
cyclohexanecarboxylic acidmonocarboxylic acid00low000000
diphenylacetic acidmonocarboxylic acidxenobiotic metabolite00low000000
dichlorproparomatic ether;
dichlorobenzene;
monocarboxylic acid
00low000000
amprotropinemonocarboxylic acid00low000000
cyanoacetic acidmonocarboxylic acid00low000000
difluoroacetic acidmonocarboxylic acid;
organofluorine compound
00low000000
5-methylpyrazole-3-carboxylic acidmonocarboxylic acid;
pyrazoles
metabolite00low000000
hydantoic acidmonocarboxylic acid;
N-acylglycine;
ureas
rat metabolite;
xenobiotic metabolite
00low000000
abietic acidabietane diterpenoid;
monocarboxylic acid
plant metabolite00low000000
3,5-dibromotyrosinemonocarboxylic acid00low000000
3-aminobutyric acidamino acid zwitterion;
beta-amino acid;
monocarboxylic acid
metabolite00low000000
4-carboxybenzaladehydebenzaldehydes;
benzoic acids;
monocarboxylic acid
plant metabolite00low000000
3-hydroxybenzeneacetic acidmonocarboxylic acid;
phenols
human xenobiotic metabolite00low000000
methoxyacetic acidether;
monocarboxylic acid
antineoplastic agent;
apoptosis inducer;
human xenobiotic metabolite;
mutagen
00low000000
dibromoacetic acid2-bromocarboxylic acid;
monocarboxylic acid
apoptosis inducer;
geroprotector;
marine metabolite
00low000000
hadacidinaldehyde;
monocarboxylic acid;
N-hydroxy-alpha-amino-acid
antimicrobial agent;
antineoplastic agent;
Penicillium metabolite;
teratogenic agent
00low000000
3-hydroxypicolinic acidmonocarboxylic acid;
monohydroxypyridine
MALDI matrix material00low000000
dihydroferulic acidguaiacols;
monocarboxylic acid;
phenylpropanoid
antioxidant;
human xenobiotic metabolite;
mouse metabolite;
plant metabolite
00low000000
ibufenacmonocarboxylic acidEC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
hepatotoxic agent;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug
00low000000
cyclopropanecarboxylic acidcyclopropanes;
monocarboxylic acid
00low000000
(4-tert-Butyl-phenoxy)-acetic acidmonocarboxylic acid00low000000
3-methoxyphenylacetic acidmonocarboxylic acid00low000000
4-chlorophenylacetic acidmonocarboxylic acid;
monochlorobenzenes
xenobiotic metabolite00low000000
4-hydroxyphenoxyacetic acidmonocarboxylic acid00low000000
5-phenylvaleric acidbenzenes;
monocarboxylic acid
00low000000
2-(4-chlorophenoxy)propionic acidmonocarboxylic acidphenoxy herbicide00low000000
bumadizonecarbohydrazide;
monocarboxylic acid
antipyretic;
non-steroidal anti-inflammatory drug
00low000000
phenoxyacetic acidaromatic ether;
monocarboxylic acid
allergen;
Aspergillus metabolite;
human xenobiotic metabolite;
plant growth retardant
00low000000
nafenopinaromatic ether;
monocarboxylic acid
00low000000
3-phenylbutyric acidbenzenes;
monocarboxylic acid
antibacterial agent;
bacterial xenobiotic metabolite
00low000000
ochratoxin bisochromanes;
monocarboxylic acid;
N-acyl-L-phenylalanine;
phenylalanine derivative
Aspergillus metabolite;
calcium channel blocker;
mycotoxin;
Penicillium metabolite
00low000000
cyclohexaneacetic acidmonocarboxylic acid00low000000
glucoheptonatecarbohydrate acid;
monocarboxylic acid
metabolite00low000000
alclofenacaromatic ether;
monocarboxylic acid;
monochlorobenzenes
drug allergen;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug
00low000000
6-methoxy-2-naphthylacetic acidmethoxynaphthalene;
monocarboxylic acid
drug metabolite;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
xenobiotic metabolite
00low000000
7-aminodesacetoxycephalosporanic acidcephalosporin;
monocarboxylic acid
00low000000
carbidopacatechols;
hydrazines;
monocarboxylic acid
antiparkinson drug;
dopaminergic agent;
EC 4.1.1.28 (aromatic-L-amino-acid decarboxylase) inhibitor
00low000000
butyl(3-carboxypropyl)nitrosaminemonocarboxylic acid;
nitrosamine
carcinogenic agent00low000000
carbidopacatechols;
hydrate;
hydrazines;
monocarboxylic acid
antidyskinesia agent;
antiparkinson drug;
dopaminergic agent;
EC 4.1.1.28 (aromatic-L-amino-acid decarboxylase) inhibitor
00low000000
ticrynafenaromatic ether;
aromatic ketone;
dichlorobenzene;
monocarboxylic acid;
thiophenes
antihypertensive agent;
hepatotoxic agent;
loop diuretic
00low000000
2-(4-(2,4-dichlorophenoxy)phenoxy)propionic acidaromatic ether;
dichlorobenzene;
diether;
monocarboxylic acid
00low000000
bezafibratearomatic ether;
monocarboxylic acid amide;
monocarboxylic acid;
monochlorobenzenes
antilipemic drug;
environmental contaminant;
geroprotector;
xenobiotic
00low000000
lonidaminedichlorobenzene;
indazoles;
monocarboxylic acid
antineoplastic agent;
antispermatogenic agent;
EC 2.7.1.1 (hexokinase) inhibitor;
geroprotector
00low000000
benoxaprofen1,3-benzoxazoles;
monocarboxylic acid;
monochlorobenzenes
antipsoriatic;
antipyretic;
EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor;
hepatotoxic agent;
nephrotoxin;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
protein kinase C agonist
00low000000
6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acidchromanol;
monocarboxylic acid;
phenols
antioxidant;
ferroptosis inhibitor;
neuroprotective agent;
radical scavenger;
Wnt signalling inhibitor
00low000000
triclopyraromatic ether;
chloropyridine;
monocarboxylic acid
agrochemical;
environmental contaminant;
herbicide;
xenobiotic
00low000000
acifluorfenaromatic ether;
benzoic acids;
C-nitro compound;
monocarboxylic acid;
organochlorine compound;
organofluorine compound
agrochemical;
EC 1.3.3.4 (protoporphyrinogen oxidase) inhibitor;
herbicide
00low000000
4,5-amino-3,5-dichloro-6-fluoro-2-pyridinyloxyacetic acidaminopyridine;
aromatic ether;
monocarboxylic acid;
organochlorine compound;
organofluorine compound
environmental contaminant;
herbicide;
xenobiotic
00low000000
haloxyfoparomatic ether;
monocarboxylic acid;
organochlorine compound;
organofluorine compound;
pyridines
00low000000
pefloxacinfluoroquinolone antibiotic;
monocarboxylic acid;
N-alkylpiperazine;
N-arylpiperazine;
quinolone antibiotic;
quinolone
antibacterial drug;
antiinfective agent;
DNA synthesis inhibitor
00low000000
imazaquinimidazolone;
monocarboxylic acid;
quinolinemonocarboxylic acid
00low000000
difloxacinfluoroquinolone antibiotic;
monocarboxylic acid;
monofluorobenzenes;
N-alkylpiperazine;
N-arylpiperazine;
quinolone antibiotic;
quinolone
antibacterial drug;
Mycoplasma genitalium metabolite
00low000000
brequinarbiphenyls;
monocarboxylic acid;
monofluorobenzenes;
quinolinemonocarboxylic acid
anticoronaviral agent;
antimetabolite;
antineoplastic agent;
antiviral agent;
EC 1.3.5.2 [dihydroorotate dehydrogenase (quinone)] inhibitor;
immunosuppressive agent;
pyrimidine synthesis inhibitor
00low000000
temafloxacinamino acid;
monocarboxylic acid;
N-arylpiperazine;
organofluorine compound;
quinolone antibiotic;
quinolone;
secondary amino compound;
tertiary amino compound
00low000000
adapaleneadamantanes;
monocarboxylic acid;
naphthoic acid
dermatologic drug;
EC 2.7.11.22 (cyclin-dependent kinase) inhibitor;
non-steroidal anti-inflammatory drug
00low000000
valsartanbiphenylyltetrazole;
monocarboxylic acid amide;
monocarboxylic acid
angiotensin receptor antagonist;
antihypertensive agent;
environmental contaminant;
xenobiotic
00low000000
fenofibric acidaromatic ketone;
chlorobenzophenone;
monocarboxylic acid
drug metabolite;
marine xenobiotic metabolite
00low000000
salvinabietane diterpenoid;
carbotricyclic compound;
catechols;
monocarboxylic acid
angiogenesis modulating agent;
anti-inflammatory agent;
antineoplastic agent;
antioxidant;
apoptosis inducer;
food preservative;
HIV protease inhibitor;
plant metabolite
00low000000
tetraiodothyroacetic acid2-halophenol;
aromatic ether;
iodophenol;
monocarboxylic acid
apoptosis inducer;
human metabolite;
thyroid hormone
00low000000
etofibratemonocarboxylic acid00low000000
fradafibancarboxamidine;
monocarboxylic acid;
pyrrolidin-2-ones
platelet glycoprotein-IIb/IIIa receptor antagonist00low000000
phenylacetylglycinemonocarboxylic acid amide;
monocarboxylic acid;
N-acylglycine
human metabolite;
mouse metabolite
00low000000
lonazolacmonocarboxylic acid;
monochlorobenzenes;
pyrazoles
antineoplastic agent;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug
00low000000
miroprofenimidazopyridine;
monocarboxylic acid
antipyretic;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
platelet aggregation inhibitor
00low000000
flunoxaprofen1,3-benzoxazoles;
monocarboxylic acid;
organofluorine compound
antirheumatic drug;
hepatotoxic agent;
non-steroidal anti-inflammatory drug;
protein kinase C agonist
00low000000
tianeptinedibenzothiazepine;
monocarboxylic acid;
organochlorine compound
00low000000
binifibratemonocarboxylic acid00low000000
5-imidazolepropionic acidimidazoles;
monocarboxylic acid
00low000000
aceclofenacamino acid;
carboxylic ester;
dichlorobenzene;
monocarboxylic acid;
secondary amino compound
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug
00low000000
gr 1172891-benzofurans;
biaryl;
imidazolyl carboxylic acid;
monocarboxylic acid;
organobromine compound;
organochlorine compound;
tetrazoles
angiotensin receptor antagonist;
antihypertensive agent
00low000000
alborixincyclic hemiketal;
monocarboxylic acid;
oxolanes;
polyether antibiotic
ionophore00low000000
madecassic acidmonocarboxylic acid;
pentacyclic triterpenoid;
tetrol
antioxidant;
plant metabolite
00low000000
monotropeinbeta-D-glucoside;
cyclopentapyran;
iridoid monoterpenoid;
monocarboxylic acid;
monosaccharide derivative
anti-inflammatory agent;
metabolite
00low000000
3-(3,4-dimethoxyphenyl)propanoic aciddimethoxybenzene;
monocarboxylic acid
00low000000
n-methylhippuric acidmonocarboxylic acid;
N-acylglycine
EC 1.1.1.21 (aldehyde reductase) inhibitor00low000000
methylimidazoleacetic acidimidazoles;
monocarboxylic acid
GABA agonist;
metabolite
00low000000
6-carboxyfluoresceinmonocarboxylic acid00low000000
4-(2-thienyl)butyric acidmonocarboxylic acid;
thiophenes
hapten00low000000
3-(trimethylsilyl)propionic acidmonocarboxylic acid;
organosilicon compound
NMR chemical shift reference compound00low000000
3-(4'-hydroxyl-3',5'-dimethoxyphenyl)propionic acidbenzenes;
monocarboxylic acid
00low000000
ritalinic acidmonocarboxylic acid;
piperidines
drug metabolite;
marine xenobiotic metabolite
00low000000
indole-1-acetic acidindolyl carboxylic acid;
monocarboxylic acid
00low000000
(1-hydroxycyclopentyl)phenylacetic acidmonocarboxylic acid;
tertiary alcohol
00low000000
fluazifoparomatic ether;
monocarboxylic acid;
organofluorine compound;
pyridines
00low000000
quincloracmonocarboxylic acid;
organochlorine compound;
quinolinemonocarboxylic acid
agrochemical;
herbicide;
synthetic auxin
00low000000
gypsogeninaldehyde;
monocarboxylic acid;
pentacyclic triterpenoid;
sapogenin
00low000000
beta-hydroxyphenylpropionic acid3-hydroxy carboxylic acid;
monocarboxylic acid
00low000000
salicylamide-2-acetic acidmonocarboxylic acid00low000000
dehydroabietic acidabietane diterpenoid;
carbotricyclic compound;
monocarboxylic acid
allergen;
metabolite
00low000000
2,6-dichloroisonicotinic acidmonocarboxylic acid;
organochlorine compound;
pyridines
EC 1.11.1.11 (L-ascorbate peroxidase) inhibitor00low000000
1-phenazinecarboxylic acidaromatic carboxylic acid;
monocarboxylic acid;
phenazines
antifungal agent;
antimicrobial agent;
bacterial metabolite
00low000000
imidazoleacetic acidimidazoles;
monocarboxylic acid
metabolite;
mouse metabolite
00low000000
2'-(2-hydroxyphenyl)-2'-thiazoline-4'-carboxylic acidimidothioate;
monocarboxylic acid
00low000000
alpha-methylphenylalaninebenzenes;
monocarboxylic acid
00low000000
aristolochic acid iiaristolochic acids;
aromatic ether;
C-nitro compound;
cyclic acetal;
monocarboxylic acid;
organic heterotetracyclic compound
carcinogenic agent;
metabolite;
mutagen;
nephrotoxin;
toxin
00low000000
4'-hydroxydiclofenacdichlorobenzene;
monocarboxylic acid;
phenols;
secondary amino compound
allergen;
drug metabolite
00low000000
asiatic acidmonocarboxylic acid;
pentacyclic triterpenoid;
triol
angiogenesis modulating agent;
metabolite
00low000000
bw 245cimidazolidine-2,4-dione;
monocarboxylic acid;
secondary alcohol
00low000000
piscidic acidbenzenes;
monocarboxylic acid
00low000000
mitiglinidebenzenes;
monocarboxylic acid
00low000000
celastrolmonocarboxylic acid;
pentacyclic triterpenoid
anti-inflammatory drug;
antineoplastic agent;
antioxidant;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
Hsp90 inhibitor;
metabolite
00low000000
4-carboxyfluoresceinmonocarboxylic acidfluorochrome00low000000
vadimezanmonocarboxylic acid;
xanthones
antineoplastic agent00low000000
ectoine1,4,5,6-tetrahydropyrimidines;
carboxamidine;
monocarboxylic acid;
zwitterion
osmolyte00low000000
chrysobactincatechols;
dipeptide;
monocarboxylic acid;
primary alcohol;
primary amino compound
bacterial metabolite;
siderophore
00low000000
cd 437adamantanes;
monocarboxylic acid;
naphthoic acid;
phenols
apoptosis inducer;
retinoic acid receptor gamma agonist
00low000000
agn 190299monocarboxylic acid;
pyridines;
retinoid;
thiochromane
keratolytic drug;
teratogenic agent
00low000000
3-bromotyrosinemonocarboxylic acid00low000000
cox 189amino acid;
monocarboxylic acid;
organochlorine compound;
organofluorine compound;
secondary amino compound
cyclooxygenase 2 inhibitor;
non-steroidal anti-inflammatory drug
00low000000
varespladibaromatic ether;
benzenes;
dicarboxylic acid monoamide;
indoles;
monocarboxylic acid;
primary carboxamide
anti-inflammatory drug;
antidote;
EC 3.1.1.4 (phospholipase A2) inhibitor
00low000000
naproxenmethoxynaphthalene;
monocarboxylic acid
antipyretic;
cyclooxygenase 1 inhibitor;
cyclooxygenase 2 inhibitor;
drug allergen;
environmental contaminant;
gout suppressant;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
xenobiotic
00low000000
clofibridemonocarboxylic acid00low000000
carbazic acidmonocarboxylic acid;
one-carbon compound
00low000000
endocrocinmonocarboxylic acid;
phenols;
trihydroxyanthraquinone
metabolite00low000000
3,5-diiodothyropropionic acidaromatic ether;
monocarboxylic acid;
organoiodine compound;
phenols
00low000000
aristolochic acid Daristolochic acids;
aromatic ether;
C-nitro compound;
cyclic acetal;
monocarboxylic acid;
organic heterotetracyclic compound
carcinogenic agent;
metabolite;
nephrotoxin;
toxin
00low000000
3,5-dihydroxyphenylpropionic acidbenzenes;
monocarboxylic acid
00low000000
acetyl aleuritolic acidacetate ester;
monocarboxylic acid;
pentacyclic triterpenoid
antineoplastic agent;
plant metabolite
00low000000
fukiic acidbenzenes;
monocarboxylic acid
00low000000
delta-1-piperidine-6-carboxylic acidmonocarboxylic acid;
tetrahydropyridine
mammalian metabolite00low000000
aristolochic acid caristolochic acids;
aromatic ether;
C-nitro compound;
cyclic acetal;
monocarboxylic acid;
organic heterotetracyclic compound
carcinogenic agent;
metabolite;
mutagen;
nephrotoxin;
toxin
00low000000
3-hydroxy-5-cholestenoic acid3beta-hydroxy-Delta(5)-steroid;
3beta-sterol;
cholestanoid;
monocarboxylic acid;
steroid acid
bacterial metabolite00low000000
enrasentanaromatic ether;
benzodioxoles;
indanes;
monocarboxylic acid;
monomethoxybenzene;
primary alcohol
antihypertensive agent;
endothelin receptor antagonist
00low000000
quizalofoparomatic ether;
monocarboxylic acid;
organochlorine compound;
quinoxaline derivative
00low000000
9-mercaptodethiobiotinimidazolidinone;
monocarboxylic acid;
thiol;
ureas
Escherichia coli metabolite00low000000
proclavaminic acidamino acid zwitterion;
azetidines;
monocarboxylic acid
00low000000
orantinibmonocarboxylic acid;
oxindoles;
pyrroles
antineoplastic agent;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor;
vascular endothelial growth factor receptor antagonist
00low000000
deferasiroxbenzoic acids;
monocarboxylic acid;
phenols;
triazoles
iron chelator00low000000
sandaracopimaric acidmonocarboxylic acid;
pimarane diterpenoid;
tricyclic diterpenoid
plant metabolite00low000000
7-methoxycoumarin-4-acetic acidmonocarboxylic acidfluorochrome00low000000
monensincyclic hemiketal;
monocarboxylic acid;
polyether antibiotic;
spiroketal
antifungal agent;
coccidiostat;
ionophore
00low000000
isopimaric acidcarbotricyclic compound;
diterpenoid;
monocarboxylic acid
00low000000
nanaomycin abenzoisochromanequinone;
monocarboxylic acid;
organooxygen heterocyclic antibiotic;
p-quinones
bacterial metabolite00low000000
theogallingallate ester;
monocarboxylic acid;
tertiary alcohol
00low000000
bispyribacaromatic ether;
benzoic acids;
monocarboxylic acid;
pyrimidines
herbicide00low000000
pyochelinmonocarboxylic acid;
phenols;
thiazolidines
metabolite;
siderophore
00low000000
yersiniabactinmonocarboxylic acid;
phenols;
secondary alcohol;
thiazolidines
bacterial metabolite;
siderophore
00low000000
mycophenolic acid2-benzofurans;
gamma-lactone;
monocarboxylic acid;
phenols
anticoronaviral agent;
antimicrobial agent;
antineoplastic agent;
EC 1.1.1.205 (IMP dehydrogenase) inhibitor;
environmental contaminant;
immunosuppressive agent;
mycotoxin;
Penicillium metabolite;
xenobiotic
00low000000
mupirocinalpha,beta-unsaturated carboxylic ester;
epoxide;
monocarboxylic acid;
oxanes;
secondary alcohol;
triol
antibacterial drug;
bacterial metabolite;
protein synthesis inhibitor
00low000000
gw 409544monocarboxylic acid00low000000
steviolbridged compound;
ent-kaurane diterpenoid;
monocarboxylic acid;
tertiary allylic alcohol;
tetracyclic diterpenoid
antineoplastic agent00low000000
bevirimatdicarboxylic acid monoester;
monocarboxylic acid;
pentacyclic triterpenoid
HIV-1 maturation inhibitor;
metabolite
00low000000
bromochloroacetic acid2-bromocarboxylic acid;
monocarboxylic acid;
organochlorine compound
00low000000
neurosporaxanthinapo carotenoid C35 terpenoid;
monocarboxylic acid
00low000000
canrenoic acid3-oxo-Delta(4) steroid;
monocarboxylic acid;
steroid acid
00low000000
dexketoprofenbenzophenones;
monocarboxylic acid
cyclooxygenase 1 inhibitor;
cyclooxygenase 2 inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug
00low000000
2-(4-ethylphenoxy)acetic acid (4-nitrophenyl) estermonocarboxylic acid00low000000
2-[4-(pyridin-4-ylmethylsulfamoyl)phenoxy]acetic acid methyl estermonocarboxylic acid00low000000
2-[2-bromo-4-(hydroxymethyl)-6-methoxyphenoxy]acetic acidmonocarboxylic acid00low000000
sulindacmonocarboxylic acid;
organofluorine compound;
sulfoxide
analgesic;
antineoplastic agent;
antipyretic;
apoptosis inducer;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
prodrug;
tocolytic agent
00low000000
epalrestatmonocarboxylic acid;
thiazolidines
EC 1.1.1.21 (aldehyde reductase) inhibitor00low000000
2-(4-bromophenoxy)acetic acid (5-phenyl-1,3,4-oxadiazol-2-yl)methyl estermonocarboxylic acid00low000000
2-(2-cyanophenoxy)acetic acid [2-(2,5-dimethyl-1-prop-2-enyl-3-pyrrolyl)-2-oxoethyl] estermonocarboxylic acid00low000000
2-(4-formylphenoxy)acetic acid [2-(4-methylanilino)-4-thiazolyl]methyl estermonocarboxylic acid00low000000
2-[4-[2-(1-cyclohexenyl)ethylsulfamoyl]-2-methylphenoxy]acetic acid methyl estermonocarboxylic acid00low000000
5-[4-(2-furylcarbonyl)piperazino]-5-oxo-3-phenylpentanoic acidbenzenes;
monocarboxylic acid
00low000000
olivetolic acidbenzoic acids;
monocarboxylic acid;
polyketide;
resorcinols
metabolite00low000000
2-[2-chloro-6-ethoxy-4-[(3-methyl-5-oxo-1-phenyl-4-pyrazolylidene)methyl]phenoxy]acetic acid methyl estermonocarboxylic acid00low000000
helvolic acid3-oxo-Delta(1) steroid;
acetate ester;
monocarboxylic acid;
steroid acid
antibacterial agent;
fungal metabolite;
mycotoxin
00low000000
6-oxopiperidine-2-carboxylatedelta-lactam;
monocarboxylic acid
bacterial metabolite00low000000
3-sulfinopropionic acidmonocarboxylic acid;
organosulfinic acid
00low000000
amibegronmonocarboxylic acid00low000000
chuangxinmycinindole alkaloid;
monocarboxylic acid;
thiinoindole
antibacterial agent;
antimicrobial agent;
bacterial metabolite;
EC 6.1.1.2 (tryptophan--tRNA ligase) inhibitor
00low000000
5-hydroxydiclofenacdichlorobenzene;
monocarboxylic acid;
phenols;
secondary amino compound
allergen;
drug metabolite
00low000000
2-oxindole-3-acetic acidindole-3-acetic acids;
monocarboxylic acid;
oxindoles
plant metabolite00low000000
2-(4-(2-carboxyethyl)phenethylamino)-5'-n-ethylcarboxamidoadenosineadenosines;
dicarboxylic acid monoamide;
monocarboxylic acid
adenosine A2A receptor agonist;
anti-inflammatory agent
00low000000
3-phenyl-3-(1-tetrazolyl)propanoic acidbenzenes;
monocarboxylic acid
00low000000
gw 7647aryl sulfide;
monocarboxylic acid;
ureas
PPARalpha agonist00low000000
l 663536aryl sulfide;
indoles;
monocarboxylic acid;
monochlorobenzenes
antineoplastic agent;
EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor;
leukotriene antagonist
00low000000
clopidogrel carboxylic acidmonocarboxylic acid;
monochlorobenzenes;
tertiary amino compound;
thienopyridine
drug metabolite;
marine xenobiotic metabolite
00low000000
4-methylene-2-octyl-5-oxo-3-oxolanecarboxylic acidgamma-lactone;
monocarboxylic acid;
tetrahydrofuranone
00low000000
2-[4-(2,5-diphenyl-3,4-dihydropyrazol-3-yl)-2-methoxyphenoxy]acetic acidmonocarboxylic acid00low000000
sm 21monocarboxylic acid00low000000
2-[4-chloro-2-[3-(4-methoxyphenyl)-4-oxo-1,2-dihydroquinazolin-2-yl]phenoxy]acetic acid methyl estermonocarboxylic acid00low000000
dinoprostmonocarboxylic acid;
prostaglandins Falpha
human metabolite;
mouse metabolite
00low000000
montelukastaliphatic sulfide;
monocarboxylic acid;
quinolines
anti-arrhythmia drug;
anti-asthmatic drug;
leukotriene antagonist
00low000000
sofalconearomatic ether;
chalcones;
monocarboxylic acid
anti-ulcer drug;
antibacterial agent;
gastrointestinal drug;
plant metabolite
00low000000
16,16-dimethylprostaglandin e2cyclopentanones;
monocarboxylic acid;
prostanoid;
secondary allylic alcohol
anti-ulcer drug;
gastrointestinal drug;
radiation protective agent
00low000000
iloprostcarbobicyclic compound;
monocarboxylic acid;
secondary alcohol
platelet aggregation inhibitor;
vasodilator agent
00low000000
rosmarinic acidcarboxylic ester;
monocarboxylic acid;
phenylpropanoid;
polyphenol
antioxidant;
EC 1.1.1.21 (aldehyde reductase) inhibitor;
non-steroidal anti-inflammatory drug;
peripheral nervous system drug;
plant metabolite;
serine proteinase inhibitor
00low000000
13,14-dihydroretinoic acidmonocarboxylic acid;
retinoid
00low000000
sulindac sulfidearyl sulfide;
monocarboxylic acid;
organofluorine compound
antineoplastic agent;
apoptosis inducer;
non-steroidal anti-inflammatory drug
00low000000
lasalocidbeta-hydroxy ketone;
monocarboxylic acid;
monohydroxybenzoic acid;
oxanes;
oxolanes;
polyether antibiotic;
secondary alcohol;
tertiary alcohol
bacterial metabolite;
coccidiostat;
ionophore
00low000000
sulindac sulfonemonocarboxylic acid;
organofluorine compound;
sulfone
apoptosis inducer;
cyclooxygenase 2 inhibitor;
EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor
00low000000
clodinafoparomatic ether;
monocarboxylic acid;
organochlorine compound;
organofluorine compound;
pyridines
EC 6.4.1.2 (acetyl-CoA carboxylase) inhibitor;
phenoxy herbicide
00low000000
robenacoxibaromatic amino acid;
monocarboxylic acid;
organofluorine compound;
phenylacetic acids;
secondary amino compound
cyclooxygenase 2 inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug
00low000000
sdz eaa 494monocarboxylic acid;
olefinic compound;
phosphonic acids;
piperazinecarboxylic acid;
tertiary amino compound
anticonvulsant;
neuroprotective agent;
NMDA receptor antagonist
00low000000
valerenic acidcarbobicyclic compound;
monocarboxylic acid;
sesquiterpenoid
GABA modulator;
plant metabolite;
sedative;
volatile oil component
00low000000
ici 215001monocarboxylic acid00low000000
beraprostenyne;
monocarboxylic acid;
organic heterotricyclic compound;
secondary alcohol;
secondary allylic alcohol
anti-inflammatory agent;
antihypertensive agent;
platelet aggregation inhibitor;
prostaglandin receptor agonist;
vasodilator agent
00low000000
gemifloxacin1,8-naphthyridine derivative;
fluoroquinolone antibiotic;
monocarboxylic acid;
quinolone antibiotic
antibacterial drug;
antimicrobial agent;
topoisomerase IV inhibitor
00low000000
gw 5015161,3-thiazoles;
aromatic ether;
aryl sulfide;
monocarboxylic acid;
organofluorine compound
carcinogenic agent;
PPARbeta/delta agonist
00low000000
brl 37344monocarboxylic acid00low000000
cp533536monocarboxylic acid00low000000
mre 269aromatic amine;
ether;
monocarboxylic acid;
pyrazines;
sulfonamide;
tertiary amino compound
drug metabolite;
orphan drug;
platelet aggregation inhibitor;
prostacyclin receptor agonist;
vasodilator agent
00low000000
gw0742monocarboxylic acid00low000000
4alpha-methylergosta-8,24(28)-dien-3,7,11-trione-26-oic acid11-oxo steroid;
3-oxo steroid;
7-oxo steroid;
ergostanoid;
monocarboxylic acid;
steroid acid
anti-inflammatory agent;
antineoplastic agent;
plant metabolite
00low000000
carmineC-glycosyl compound;
monocarboxylic acid;
tetrahydroxyanthraquinone
animal metabolite;
histological dye
00low000000
ki16425carbamate ester;
isoxazoles;
monocarboxylic acid;
monochlorobenzenes;
organic sulfide
00low000000
myrsinoic acid b1-benzofurans;
monocarboxylic acid
anti-inflammatory agent;
EC 4.4.1.11 (methionine gamma-lyase) inhibitor;
metabolite
00low000000
triptohypol Cbenzenediols;
monocarboxylic acid;
pentacyclic triterpenoid
apoptosis inducer;
plant metabolite
00low000000
artemisic acidcarbobicyclic compound;
monocarboxylic acid;
octahydronaphthalenes;
sesquiterpenoid
metabolite00low000000
tafamidis1,3-benzoxazoles;
dichlorobenzene;
monocarboxylic acid
central nervous system drug00low000000
dihydroartemisinic acidcarbobicyclic compound;
monocarboxylic acid;
octahydronaphthalenes;
sesquiterpenoid
plant metabolite00low000000
finafloxacincyclopropanes;
monocarboxylic acid;
nitrile;
organofluorine compound;
quinolone;
secondary amino compound;
tertiary amino compound
antibacterial drug;
antimicrobial agent
00low000000
pyrostatin a1,4,5,6-tetrahydropyrimidines;
carboxamidine;
iminium betaine;
monocarboxylic acid;
secondary alcohol
00low000000
roburic acidmonocarboxylic acid;
olefinic compound;
tetracyclic triterpenoid
plant metabolite00low000000
imidazoleacetic acid ribotideimidazoles;
monocarboxylic acid;
N-glycosyl compound;
ribose monophosphate
00low000000
vanchrobactincatechols;
dipeptide;
guanidines;
monocarboxylic acid;
primary alcohol;
triol
bacterial metabolite;
marine metabolite;
siderophore
00low000000
spongia-13(16),14-dien-19-oic acidcyclic ether;
monocarboxylic acid;
tetracyclic diterpenoid
androgen antagonist;
metabolite
00low000000
cathestatin bdicarboxylic acid monoamide;
epoxide;
monocarboxylic acid;
phenols;
primary amino compound
antimicrobial agent;
cysteine protease inhibitor;
Penicillium metabolite
00low000000
borrelidinaliphatic nitrile;
diol;
macrolide;
monocarboxylic acid;
secondary alcohol
antifungal agent;
antimalarial;
antimicrobial agent;
antineoplastic agent;
apoptosis inducer;
bacterial metabolite
00low000000
germacra-1(10),4,11(13)-trien-12-oic acidgermacrane sesquiterpenoid;
monocarboxylic acid
00low000000
ascr#5monocarboxylic acid;
omega-hydroxy fatty acid ascaroside
Caenorhabditis elegans metabolite;
pheromone
00low000000
tropodithietic acidcyclic ketone;
monocarboxylic acid;
organic disulfide;
organic heterobicyclic compound;
organosulfur heterocyclic compound
antibacterial agent;
bacterial metabolite;
marine metabolite;
signalling molecule;
toxin
00low000000
fumimycin1-benzofurans;
dicarboxylic acid monoamide;
gamma-lactone;
monocarboxylic acid;
polyphenol
antibacterial agent;
Aspergillus metabolite;
EC 3.5.1.88 (peptide deformylase) inhibitor
00low000000
3alpha,12alpha-dihydroxy-4alpha-methylergosta-8,24(28)-dien-7,11-dione-26-oic acid11-oxo steroid;
12alpha-hydroxy steroid;
3alpha-hydroxy steroid;
7-oxo steroid;
monocarboxylic acid;
secondary alpha-hydroxy ketone;
steroid acid
antineoplastic agent;
metabolite
00low000000
3alpha-hydroxy-4alpha-methylergosta-8,24(28)-dien-7,11-dione-26-oic acid11-oxo steroid;
3alpha-hydroxy steroid;
7-oxo steroid;
monocarboxylic acid;
steroid acid
antineoplastic agent;
cholinergic antagonist;
metabolite;
serotonergic antagonist
00low000000
lesinuradaryl sulfide;
cyclopropanes;
monocarboxylic acid;
naphthalenes;
organobromine compound;
triazoles
uricosuric drug00low000000
saroglitazararomatic ether;
methyl sulfide;
monocarboxylic acid;
pyrroles
hypoglycemic agent;
PPARalpha agonist;
PPARgamma agonist
00low000000
gsk2879552benzenes;
benzoic acids;
cyclopropanes;
monocarboxylic acid;
piperidines;
secondary amino compound;
tertiary amino compound
antineoplastic agent;
EC 1.14.99.66 (lysine-specific histone demethylase 1A) inhibitor
00low000000
benzenearomatic annulene;
benzenes;
volatile organic compound
carcinogenic agent;
environmental contaminant;
non-polar solvent
00low000000
gallopamilbenzenes;
organic amino compound
00low000000
mandelic acid2-hydroxy monocarboxylic acid;
benzenes
antibacterial agent;
human xenobiotic metabolite
00low000000
4-phenyl-3-furoxancarbonitrile1,2,5-oxadiazole;
benzenes;
N-oxide;
nitrile
geroprotector;
nitric oxide donor;
platelet aggregation inhibitor;
soluble guanylate cyclase activator;
vasodilator agent
00low000000
bencyclanebenzenes00low000000
benzamidinebenzenes;
carboxamidine
serine protease inhibitor00low000000
benzyl isothiocyanatebenzenes;
isothiocyanate
antibacterial drug00low000000
benzylhydrochlorothiazidebenzenes;
benzothiadiazine;
organochlorine compound;
secondary amino compound;
sulfonamide
00low000000
carbetapentanebenzenes00low000000
chlorprophambenzenes;
carbamate ester;
monochlorobenzenes
herbicide;
plant growth retardant
00low000000
cimaterolbenzenes;
nitrile
00low000000
clofiliumbenzenes;
organic amino compound
00low000000
diphenidolbenzenes;
piperidines;
tertiary alcohol
antiemetic00low000000
cycloadipheninebenzenes00low000000
fenipentolbenzenes00low000000
2-cyclopentyl-2-hydroxy-2-phenylacetic acid (1,1-dimethyl-3-pyrrolidin-1-iumyl) esterbenzenes00low000000
lidocainebenzenes;
monocarboxylic acid amide;
tertiary amino compound
anti-arrhythmia drug;
drug allergen;
environmental contaminant;
local anaesthetic;
xenobiotic
00low000000
isocarboxazidbenzenes00low000000
labetalolbenzamides;
benzenes;
phenols;
primary carboxamide;
salicylamides;
secondary alcohol;
secondary amino compound
00low000000
methadonebenzenes;
diarylmethane;
ketone;
tertiary amino compound
00low000000
metolachloraromatic amide;
benzenes;
ether;
organochlorine compound
00low000000
nafoxidinebenzenes;
naphthalenes;
ring assembly
00low000000
nicardipinebenzenes;
C-nitro compound;
diester;
dihydropyridine;
methyl ester;
tertiary amino compound
00low000000
phenprobamatebenzenes00low000000
sulfabenzamidebenzenes;
sulfonamide antibiotic;
sulfonamide
antibacterial drug;
antimicrobial drug
00low000000
sulfacytinebenzenes;
sulfonamide
00low000000
sulfamonomethoxinebenzenes;
sulfonamide
00low000000
sulfaquinoxalinebenzenes;
sulfonamide
00low000000
2-phenylcyclopropan-1-aminebenzenes;
cyclopropanes;
primary amine
00low000000
tolazoline hydrochloridebenzenes00low000000
phenylethyl alcoholbenzenes;
primary alcohol
Aspergillus metabolite;
fragrance;
plant growth retardant;
plant metabolite;
Saccharomyces cerevisiae metabolite
00low000000
mebanazinebenzenes00low000000
phencyclidinebenzenes;
piperidines
anaesthetic;
neurotoxin;
NMDA receptor antagonist;
psychotropic drug
00low000000
caramiphenbenzenes00low000000
acetyl sulfisoxazolebenzenes;
sulfonamide
00low000000
diphenylaromatic fungicide;
benzenes;
biphenyls
antifungal agrochemical;
antimicrobial food preservative
00low000000
styrene glycolbenzenes00low000000
sulfaethidolebenzenes;
sulfonamide
00low000000
benzotrichloridebenzenes;
organochlorine compound;
volatile organic compound
carcinogenic agent00low000000
benzal chloridebenzenes00low000000
benzoyl chlorideacyl chloride;
benzenes
carcinogenic agent00low000000
benzonitrilebenzenes;
nitrile
00low000000
methylphenylsulfidearyl sulfide;
benzenes
00low000000
methyl phenylacetatebenzenes00low000000
ethyl phenylacetatebenzenes00low000000
phenyl isocyanatebenzenes;
isocyanates
allergen;
hapten
00low000000
3-phenylpropanalaldehyde;
benzenes
flavouring agent;
plant metabolite
00low000000
1,4-diethylbenzenebenzenes00low000000
benzyl cyanidebenzenes;
nitrile
animal metabolite;
pheromone
00low000000
pivalylbenzhydrazinebenzenes00low000000
mexacarbatebenzenes00low000000
carbutamidebenzenes;
sulfonamide
00low000000
methaphenilenebenzenes00low000000
biphenylacetylenearylacetylene;
benzenes
fluorochrome00low000000
beclamidebenzenes00low000000
mepiperphenidolbenzenes;
organic amino compound
00low000000
glybuthiazolbenzenes;
sulfonamide
00low000000
phenylacetylenebenzenes00low000000
sulfanilylureabenzenes;
sulfonamide
00low000000
metahexamidebenzenes;
sulfonamide
00low000000
nitrosobenzenebenzenes;
nitroso compound
xenobiotic metabolite00low000000
triphenylphosphinebenzenes;
tertiary phosphine
NMR chemical shift reference compound;
reducing agent
00low000000
2-cyanophenolbenzenes;
nitrile
00low000000
bensulidebenzenes00low000000
1-phenylcyclohex-1-enebenzenes00low000000
diphenyl disulfidebenzenes00low000000
2-phenylpropanolbenzenes00low000000
methyl phenyl sulfoxidebenzenes;
sulfoxide
00low000000
2,6-dimethoxybenzoic acidbenzenes;
carbonyl compound
00low000000
phenylphosphonic acidbenzenes00low000000
pyrazonbenzenes;
organochlorine compound;
primary amino compound;
pyridazinone
environmental contaminant;
herbicide;
xenobiotic
00low000000
3-phenylpropylaminebenzenes;
phenylalkylamine;
primary amino compound
00low000000
aminorexbenzenes00low000000
bitoscanatebenzenes00low000000
teclozanbenzenes00low000000
dioxacarbbenzenes00low000000
fenestrelbenzenes00low000000
prophambenzenes;
carbamate ester
herbicide;
plant growth retardant
00low000000
cyanophenphosbenzenes;
nitrile
00low000000
N'-methyl-N,N-diphenylureabenzenes00low000000
dibenzo-18-crown-6benzenes;
crown ether
phase-transfer catalyst00low000000
clobutinolbenzenes;
organic amino compound
00low000000
phenyl acetatebenzenes;
phenyl acetates
00low000000
ripazepambenzenes00low000000
u 40481benzenes;
formamidines
marine xenobiotic metabolite00low000000
iprodionebenzenes;
dichlorophenyl dicarboximide fungicide;
imidazole fungicide;
imidazolidine-2,4-dione;
ureas
antifungal agrochemical;
nematicide
00low000000
clorsulonbenzenes;
sulfonamide
00low000000
ibutilidebenzenes;
organic amino compound
00low000000
prosulfocarbbenzenes;
monothiocarbamic ester
environmental contaminant;
herbicide;
xenobiotic
00low000000
Isopropyl phenylacetatebenzenes00low000000
4-methyl-1-phenylpentan-2-olbenzenes00low000000
magnesium salicylatebenzenes;
carbonyl compound
00low000000
plerixaforazacycloalkane;
azamacrocycle;
benzenes;
crown amine;
secondary amino compound;
tertiary amino compound
anti-HIV agent;
antineoplastic agent;
C-X-C chemokine receptor type 4 antagonist;
immunological adjuvant
00low000000
tribuzonebenzenes00low000000
phenylpropiolic acidacetylenic compound;
alpha,beta-unsaturated monocarboxylic acid;
benzenes
00low000000
2-Oxo-4-phenylbutyric acidbenzenes00low000000
emopamilbenzenes;
organic amino compound
00low000000
bathophenanthrolinebenzenes;
phenanthrolines
chelator00low000000
2-aminobenzenesulfonamidebenzenes;
sulfonamide
00low000000
3-phenylpropyl isothiocyanatebenzenes00low000000
4-chloro-5-sulfamoylanthranilic acidbenzenes;
sulfonamide
00low000000
phenylheptatriynebenzenes00low000000
methyl mandelatebenzenes00low000000
benzylphosphonic acidbenzenes00low000000
9,10-bis(phenylethynyl)anthraceneanthracenes;
arylacetylene;
benzenes
fluorochrome00low000000
4-phenylbutylaminebenzenes;
phenylalkylamine;
primary amino compound
00low000000
sddsbenzenes;
sulfonamide
00low000000
1-hydroxy-1-phenyl-2-propanonebenzenes;
methyl ketone;
secondary alpha-hydroxy ketone
00low000000
silomatbenzenes;
organic amino compound
00low000000
phenylisopropyladenosinearomatic amine;
benzenes;
hydrocarbyladenosine;
purine nucleoside;
secondary amino compound
adenosine A1 receptor agonist;
neuroprotective agent
00low000000
alpha-Cyclohexylmandelic acidbenzenes00low000000
1-amino-1-phenylmethyl phosphonic acidbenzenes;
phosphonic acids;
primary amino compound
00low000000
n-(4-(7-diethylamino-4-methylcoumarin-3-yl)phenyl)maleimidebenzenes;
coumarins;
maleimides;
tertiary amino compound
fluorescent dye00low000000
4-phenylbutyl isothiocyanatebenzenes;
organic amino compound
00low000000
n-acetylphenelzinebenzenes00low000000
forasartanbenzenes;
pyridines;
tetrazoles;
triazoles
angiotensin receptor antagonist;
antihypertensive agent
00low000000
desethyloxybutyninbenzenes00low000000
monodesmethylcitaloprambenzenes;
organic amino compound
00low000000
cyclodrinebenzenes00low000000
didesmethylcitaloprambenzenes;
organic amino compound
00low000000
carlina oxidebenzenes00low000000
4-butyl-4-(hydroxymethyl)-1,2-diphenylpyrazolidine-3,5-dionebenzenes00low000000
2-[(3-oxo-1-cyclohexenyl)amino]benzonitrilebenzenes;
nitrile
00low000000
benzyl d-glucopyranosidebenzenes;
beta-D-glucoside
plant metabolite00low000000
cafenstrolebenzenes;
sulfone;
triazoles
agrochemical;
antimitotic;
herbicide
00low000000
(5-Phenyl-1,2,4-triazol-3-yl)ureabenzenes00low000000
pifithrin mubenzenes00low000000
2-(2-phenylethyl)chromonebenzenes;
chromones
plant metabolite00low000000
bms 214662benzenes;
benzodiazepine;
imidazoles;
nitrile;
sulfonamide;
thiophenes
antineoplastic agent;
apoptosis inducer;
EC 2.5.1.58 (protein farnesyltransferase) inhibitor
00low000000
N-bis(N-methylanilino)phosphoryl-N-methylanilinebenzenes00low000000
3-[di(propan-2-yl)phosphorylmethyl]benzonitrilebenzenes;
nitrile
00low000000
4,5-diphenyl-1,2,3-triazolebenzenes;
ring assembly;
triazoles
00low000000
N-benzylquinazolin-4-aminebenzenes;
quinazolines;
secondary amino compound
00low000000
2-acetyl-6-amino-8-(2-phenylethyl)-1,3,8,8a-tetrahydroisoquinoline-5,7,7-tricarbonitrilebenzenes00low000000
thiobenzamidebenzenes00low000000
4-(benzylsulfanyl)thieno[2,3-d]pyrimidinearyl sulfide;
benzenes;
thienopyrimidine
00low000000
4-[(4-chloro-5-dithiazolylidene)amino]benzonitrilebenzenes;
nitrile
00low000000
N-methyl-N-phenylthioureabenzenes00low000000
3,6-dibenzyl-1,2-dihydro-1,2,4,5-tetraazinebenzenes00low000000
1-cyclohexyl-3-(2-phenylethyl)ureabenzenes00low000000
5-ethyl-1-(phenylmethyl)-1,3,5-triazinane-2-thionebenzenes00low000000
4-amino-N-(4-ethoxyphenyl)benzenesulfonamidebenzenes;
sulfonamide
00low000000
N-[5-(phenylmethyl)-1,3,4-thiadiazol-2-yl]carbamic acid methyl esterbenzenes00low000000
1,3-bis(2-phenylethyl)thioureabenzenes00low000000
8-methyl-2-phenyl-1,2,4-triazaspiro[4.5]decane-3-thionebenzenes00low000000
3-(4-ethyl-5-methyl-3-thiophenyl)-4-(phenylmethyl)-1H-1,2,4-triazole-5-thionebenzenes00low000000
4-(phenylmethyl)-3-(5-propyl-3-thiophenyl)-1H-1,2,4-triazole-5-thionebenzenes00low000000
6-(2-phenylethyl)-3-(phenylmethyl)-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazolebenzenes;
triazolothiadiazole
00low000000
4-(2-furanylmethyl)-3-(phenylmethyl)-1H-1,2,4-triazole-5-thionebenzenes00low000000
4-(1H-imidazol-1-ylmethyl)benzonitrilebenzenes;
nitrile
00low000000
N-(3-cyano-5-methyl-4-phenyl-2-thiophenyl)-3,5-dimethyl-4-isoxazolecarboxamidebenzenes00low000000
1-amino-3-[3-(2-sulfanylidene-3H-1,3,4-oxadiazol-5-yl)phenyl]thioureabenzenes00low000000
N-(3-phenylpropyl)methanesulfonamidebenzenes00low000000
1-ethyl-3-[[[(phenylmethyl)amino]-sulfanylidenemethyl]amino]thioureabenzenes00low000000
N-[[(3-cyano-4,5,6,7-tetrahydro-1-benzothiophen-2-yl)amino]-sulfanylidenemethyl]-5-methyl-3-phenyl-4-isoxazolecarboxamidebenzenes00low000000
amn082benzenes;
diamine;
diarylmethane;
secondary amino compound
metabotropic glutamate receptor agonist;
neuroprotective agent
00low000000
2-(2-furanyl)-3,5-dimethyl-4-oxido-6-phenylpyrazin-1-ium 1-oxidebenzenes00low000000
N-(3,4-dihydro-2H-pyrrol-5-yl)-5-phenyl-1,3,4-oxadiazol-2-aminebenzenes00low000000
4-butyl-3-(phenylmethyl)-1H-1,2,4-triazole-5-thionebenzenes00low000000
N1-phenethylhydrazine-1-carbothioamidebenzenes00low000000
1-hydroxy-5,5-dimethyl-2-phenyltetrahydro-4H-imidazole-4-thionebenzenes00low000000
2-[1-[2-oxo-2-[(4-thiophen-2-ylphenyl)methylamino]ethyl]cyclohexyl]acetic acidbenzenes00low000000
N-(cyclopropylmethyl)-N'-phenylureabenzenes00low000000
2-[(4-chlorophenyl)methoxy]-6-methoxybenzonitrilebenzenes;
nitrile
00low000000
2-(4-pentylphenyl)acetic acidbenzenes00low000000
5-methyl-2-phenyl-5-(2-phenylethyl)-1,2,4-triazolidine-3-thionebenzenes00low000000
k 858benzenes00low000000
4-[[[4-(2-furanylmethyl)-5-(thiophen-2-ylmethyl)-1,2,4-triazol-3-yl]thio]methyl]benzonitrilebenzenes;
nitrile
00low000000
9-oxo-N-(1-phenylethyl)-3-bicyclo[3.3.1]nonanecarboxamidebenzenes00low000000
N1,N4-bis(1-phenylethyl)cyclohexane-1,4-dicarboxamidebenzenes00low000000
4-phenyl-3H-thiazole-2-thionebenzenes00low000000
sulfatolamidebenzenes;
sulfonamide
00low000000
1-[(2-ethyl-4-hydroxy-4-methyl-1-oxopentyl)amino]-3-phenylthioureabenzenes00low000000
2-[6-amino-5-cyano-4-(4-ethylphenyl)-2,4-dihydropyrano[2,3-c]pyrazol-3-yl]acetic acid methyl esterbenzenes;
pyranopyrazole
00low000000
3,5-dimethyl-N-(2-phenylethyl)-N-(phenylmethyl)-4-isoxazolesulfonamidebenzenes00low000000
4-(2,3-dihydro-1,4-benzodioxin-3-ylmethylamino)-3-nitrobenzenesulfonamidebenzenes;
sulfonamide
00low000000
N'-[5-(phenylmethyl)-4,5-dihydrothiazol-2-yl]hexanehydrazidebenzenes00low000000
5-amino-2-(diethylamino)-N-(2-methoxyphenyl)benzenesulfonamidebenzenes;
sulfonamide
00low000000
4-(1-phenylethyl)-3-(5-propyl-3-thiophenyl)-1H-1,2,4-triazole-5-thionebenzenes00low000000
4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dionebenzenes;
thiadiazolidine
anti-inflammatory agent;
antineoplastic agent;
apoptosis inducer;
EC 2.7.11.26 (tau-protein kinase) inhibitor;
neuroprotective agent
00low000000
N-[[(3-cyano-6-methyl-4,5,6,7-tetrahydro-1-benzothiophen-2-yl)amino]-sulfanylidenemethyl]-5-methyl-3-phenyl-4-isoxazolecarboxamidebenzenes00low000000
N-[2-(4-methoxyphenyl)ethyl]-2-nitro-4-(1-pyrrolidinylsulfonyl)anilinebenzenes;
sulfonamide
00low000000
1-(1-adamantyl)-3-[1-(phenylmethyl)-4-pyrazolyl]ureabenzenes00low000000
neticonazolearomatic ether;
benzenes;
conazole antifungal drug;
enamine;
imidazole antifungal drug;
imidazoles;
methyl sulfide
antifungal drug;
EC 1.14.13.70 (sterol 14alpha-demethylase) inhibitor
00low000000
l796778benzenes;
C-nitro compound;
L-lysine derivative;
L-phenylalanine derivative;
methyl ester;
oligopeptide;
secondary carboxamide;
ureas
somatostatin receptor agonist00low000000
l803087benzenes;
fluoroindole;
guanidines;
L-arginine derivative;
methyl ester;
phenylindole;
secondary carboxamide
somatostatin receptor agonist00low000000
ro 4-6790benzenes;
sulfonamide
00low000000
bay 11-7085benzenes;
nitrile;
sulfone
anti-inflammatory agent;
antibacterial agent;
antineoplastic agent;
apoptosis inducer;
autophagy inducer;
EC 2.7.11.10 (IkappaB kinase) inhibitor;
ferroptosis inducer;
NF-kappaB inhibitor
00low000000
gluconasturtiinaralkylglucosinolic acid;
benzenes
00low000000
DPI2benzenes;
morpholines;
secondary carboxamide;
tertiary amino compound;
thiazolidinone
ferroptosis inducer00low000000
l 744832benzenes;
ether;
isopropyl ester;
secondary carboxamide;
sulfone;
thiol
antineoplastic agent;
EC 2.5.1.58 (protein farnesyltransferase) inhibitor;
geroprotector
00low000000
glucotropeolinaralkylglucosinolic acid;
benzenes
00low000000
5-(4-phenylbutoxy)psoralenaromatic ether;
benzenes;
psoralens
geroprotector;
immunosuppressive agent;
potassium channel blocker
00low000000
ro 25-6981benzenes;
phenols;
piperidines;
secondary alcohol;
tertiary amino compound
anticonvulsant;
antidepressant;
neuroprotective agent;
NMDA receptor antagonist
00low000000
bm 567benzenes;
sulfonamide
00low000000
varespladib methylaromatic ether;
benzenes;
indoles;
methyl ester;
primary carboxamide
anti-inflammatory drug;
antidote;
EC 3.1.1.4 (phospholipase A2) inhibitor;
prodrug
00low000000
npi 23582,5-diketopiperazines;
benzenes;
imidazoles;
olefinic compound
angiogenesis inhibitor;
antineoplastic agent;
apoptosis inducer;
microtubule-destabilising agent
00low000000
chlorobactenebenzenes;
carotenoid phi-end group;
carotenoid
bacterial metabolite00low000000
ws-5995 cbenzenes;
naphthalenes;
ring assembly
00low000000
phevalinbenzenes;
pyrazinone
bacterial metabolite;
calpain inhibitor
00low000000
np 031112benzenes;
naphthalenes;
thiadiazolidine
anti-inflammatory agent;
apoptosis inducer;
EC 2.7.11.26 (tau-protein kinase) inhibitor;
neuroprotective agent
00low000000
ym 2163911,3-oxazoles;
1,3-thiazoles;
azamacrocycle;
benzenes;
heterodetic cyclic peptide
antineoplastic agent;
bacterial metabolite
00low000000
3-(4-nitrophenyl)-N-(4-phenylbutyl)-5-(phenylmethyl)-4,6-dihydro-3aH-pyrrolo[3,4-d]isoxazole-6a-carboxamidebenzenes;
organic amino compound
00low000000
SYC-435benzenes;
cyclic hydroxamic acid;
pyridone
antineoplastic agent;
EC 1.1.1.42 (isocitrate dehydrogenase) inhibitor
00low000000
trelagliptinbenzenes;
nitrile
00low000000
1-hydroxy-5-nitro-N-(2-phenylethyl)-4-spiro[benzimidazole-2,1'-cyclohexane]iminebenzenes00low000000
5-methyl-5-pentyl-2-phenyl-1,2,4-triazolidine-3-thionebenzenes00low000000
N-methyl-3-[5-(3-phenylpropyl)-1,3,4-oxadiazol-2-yl]-N-(3-thiophenylmethyl)propanamidebenzenes00low000000
(5S)-1-(4-cyclohexylbutyl)-5-phenyl-4,5-dihydroimidazol-2-aminebenzenes00low000000
phenylmercuric acetatearylmercury compound;
benzenes
00low000000
sm 164benzenes;
organic heterobicyclic compound;
secondary carboxamide;
triazoles
antineoplastic agent;
apoptosis inducer;
radiosensitizing agent
00low000000
5-Methyl-1-phenyl-3-hexanyl sulfamatebenzenes00low000000
1-(3-methoxyphenyl)-3-(4-phenylbutyl)ureabenzenes;
organic amino compound
00low000000
niraparibbenzenes;
indazoles;
piperidines;
primary carboxamide
antineoplastic agent;
EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor
00low000000
n-alpha-benzoyl-n5-(2-chloro-1-iminoethyl)-l-ornithine amidebenzenes00low000000
1,1,1,2,2-pentafluoro-7-phenylheptan-3-onebenzenes00low000000
3-[[4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-1,4-diazepan-1-yl]sulfonyl]anilinebenzenes;
sulfonamide
00low000000
difenacoumbenzenes;
naphthalenes;
ring assembly
00low000000
warfarinbenzenes;
hydroxycoumarin;
methyl ketone
00low000000
bromfenacoumbenzenes;
naphthalenes;
ring assembly
00low000000
flocoumafenbenzenes;
naphthalenes;
ring assembly
00low000000
SubstanceStudiesClassesRolesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
quinacrineacridines;
aromatic ether;
organochlorine compound;
tertiary amino compound
antimalarial;
EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor
2008200816.0low000100
coumarincoumarinsfluorescent dye;
human metabolite;
plant metabolite
2005200519.0low000200
1-aminocyclopropane-1-carboxylic acidamino acid zwitterion;
monocarboxylic acid;
non-proteinogenic alpha-amino acid
ethylene releasers;
plant metabolite
2005200519.0low000100
aminocaproic acidamino acid zwitterion;
epsilon-amino acid;
omega-amino fatty acid
antifibrinolytic drug;
hematologic agent;
metabolite
2008200816.0low000100
1-(3-chlorophenyl)piperazinemonochlorobenzenes;
N-arylpiperazine
drug metabolite;
environmental contaminant;
serotonergic agonist;
xenobiotic
2008200816.0low000100
enprofyllineoxopurineanti-arrhythmia drug;
anti-asthmatic drug;
bronchodilator agent;
non-steroidal anti-inflammatory drug
2008200816.0low000100
phenytoinimidazolidine-2,4-dioneanticonvulsant;
drug allergen;
sodium channel blocker;
teratogenic agent
2005200519.0low000100
tacrineacridines;
aromatic amine
EC 3.1.1.7 (acetylcholinesterase) inhibitor2008200816.0low000100
acebutololaromatic amide;
ethanolamines;
ether;
monocarboxylic acid amide;
propanolamine;
secondary amino compound
anti-arrhythmia drug;
antihypertensive agent;
beta-adrenergic antagonist;
sympathomimetic agent
2008200816.0low000100
acetaminophenacetamides;
phenols
antipyretic;
cyclooxygenase 1 inhibitor;
cyclooxygenase 2 inhibitor;
cyclooxygenase 3 inhibitor;
environmental contaminant;
ferroptosis inducer;
geroprotector;
hepatotoxic agent;
human blood serum metabolite;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
xenobiotic
2008200816.0low000100
acetazolamidemonocarboxylic acid amide;
sulfonamide;
thiadiazoles
anticonvulsant;
diuretic;
EC 4.2.1.1 (carbonic anhydrase) inhibitor
2008200816.0low000100
albuterolphenols;
phenylethanolamines;
secondary amino compound
beta-adrenergic agonist;
bronchodilator agent;
environmental contaminant;
xenobiotic
2008200816.0low000100
alfuzosinmonocarboxylic acid amide;
quinazolines;
tetrahydrofuranol
alpha-adrenergic antagonist;
antihypertensive agent;
antineoplastic agent
2008200816.0low000100
alosetronimidazoles;
pyridoindole
antiemetic;
gastrointestinal drug;
serotonergic antagonist
2008200816.0low000100
alprazolamorganochlorine compound;
triazolobenzodiazepine
anticonvulsant;
anxiolytic drug;
GABA agonist;
muscle relaxant;
sedative;
xenobiotic
2008200816.0low000100
alprenololsecondary alcohol;
secondary amino compound
anti-arrhythmia drug;
antihypertensive agent;
beta-adrenergic antagonist;
sympatholytic agent
2008200816.0low000100
amantadineadamantanes;
primary aliphatic amine
analgesic;
antiparkinson drug;
antiviral drug;
dopaminergic agent;
NMDA receptor antagonist;
non-narcotic analgesic
2008200816.0low000100
diatrizoic acidacetamides;
benzoic acids;
organoiodine compound
environmental contaminant;
radioopaque medium;
xenobiotic
2008200816.0low000100
theophyllinedimethylxanthineadenosine receptor antagonist;
anti-asthmatic drug;
anti-inflammatory agent;
bronchodilator agent;
drug metabolite;
EC 3.1.4.* (phosphoric diester hydrolase) inhibitor;
fungal metabolite;
human blood serum metabolite;
immunomodulator;
muscle relaxant;
vasodilator agent
2008200816.0low000100
amiodarone1-benzofurans;
aromatic ketone;
organoiodine compound;
tertiary amino compound
cardiovascular drug2008200816.0low000100
amitriptylinecarbotricyclic compound;
tertiary amine
adrenergic uptake inhibitor;
antidepressant;
environmental contaminant;
tropomyosin-related kinase B receptor agonist;
xenobiotic
2008200816.0low000100
amlodipinedihydropyridine;
ethyl ester;
methyl ester;
monochlorobenzenes;
primary amino compound
antihypertensive agent;
calcium channel blocker;
vasodilator agent
2008200816.0low000100
amsacrineacridines;
aromatic ether;
sulfonamide
antineoplastic agent;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor
2008200816.0low000100
antipyrinepyrazoloneantipyretic;
cyclooxygenase 3 inhibitor;
environmental contaminant;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
xenobiotic
2005200817.5low000200
aspirinbenzoic acids;
phenyl acetates;
salicylates
anticoagulant;
antipyretic;
cyclooxygenase 1 inhibitor;
cyclooxygenase 2 inhibitor;
drug allergen;
EC 1.1.1.188 (prostaglandin-F synthase) inhibitor;
geroprotector;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
plant activator;
platelet aggregation inhibitor;
prostaglandin antagonist;
teratogenic agent
2008200816.0low000100
atenololethanolamines;
monocarboxylic acid amide;
propanolamine
anti-arrhythmia drug;
antihypertensive agent;
beta-adrenergic antagonist;
environmental contaminant;
sympatholytic agent;
xenobiotic
2008200816.0low000100
azelastinemonochlorobenzenes;
phthalazines;
tertiary amino compound
anti-allergic agent;
anti-asthmatic drug;
bronchodilator agent;
EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor;
H1-receptor antagonist;
platelet aggregation inhibitor
2008200816.0low000100
betaxololpropanolamineantihypertensive agent;
beta-adrenergic antagonist;
sympatholytic agent
2008200816.0low000100
bevantololpropanolamineanti-arrhythmia drug;
antihypertensive agent;
beta-adrenergic antagonist;
calcium channel blocker
2008200816.0low000100
biperidenpiperidines;
tertiary alcohol;
tertiary amino compound
antidote to sarin poisoning;
antidyskinesia agent;
antiparkinson drug;
muscarinic antagonist;
parasympatholytic
2008200816.0low000100
bisoprololsecondary alcohol;
secondary amine
anti-arrhythmia drug;
antihypertensive agent;
beta-adrenergic antagonist;
sympatholytic agent
2008200816.0low000100
bromazepamorganic molecular entity2008200816.0low000100
bromopridebenzamides2008200816.0low000100
brotizolamorganic molecular entity2008200816.0low000100
buflomedilaromatic ketone2008200816.0low000100
bumetanideamino acid;
benzoic acids;
sulfonamide
diuretic;
EC 3.6.3.49 (channel-conductance-controlling ATPase) inhibitor
2008200816.0low000100
bunazosinquinazolines2008200816.0low000100
bupivacainearomatic amide;
piperidinecarboxamide;
tertiary amino compound
2008200816.0low000100
busulfanmethanesulfonate esteralkylating agent;
antineoplastic agent;
carcinogenic agent;
insect sterilant;
teratogenic agent
2008200816.0low000100
caffeinepurine alkaloid;
trimethylxanthine
adenosine A2A receptor antagonist;
adenosine receptor antagonist;
adjuvant;
central nervous system stimulant;
diuretic;
EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor;
EC 3.1.4.* (phosphoric diester hydrolase) inhibitor;
environmental contaminant;
food additive;
fungal metabolite;
geroprotector;
human blood serum metabolite;
mouse metabolite;
mutagen;
plant metabolite;
psychotropic drug;
ryanodine receptor agonist;
xenobiotic
2005200817.5low000200
verapamilaromatic ether;
nitrile;
polyether;
tertiary amino compound
2008200816.0low000100
metrizoatemonocarboxylic acidradioopaque medium2008200816.0low000100
carmustineN-nitrosoureas;
organochlorine compound
alkylating agent;
antineoplastic agent
2008200816.0low000100
carvedilolcarbazoles;
secondary alcohol;
secondary amino compound
alpha-adrenergic antagonist;
antihypertensive agent;
beta-adrenergic antagonist;
cardiovascular drug;
vasodilator agent
2008200816.0low000100
chlorambucilaromatic amine;
monocarboxylic acid;
nitrogen mustard;
organochlorine compound;
tertiary amino compound
alkylating agent;
antineoplastic agent;
carcinogenic agent;
drug allergen;
immunosuppressive agent
2008200816.0low000100
chlordiazepoxidebenzodiazepine2008200816.0low000100
chloroquineaminoquinoline;
organochlorine compound;
secondary amino compound;
tertiary amino compound
anticoronaviral agent;
antimalarial;
antirheumatic drug;
autophagy inhibitor;
dermatologic drug
2008200816.0low000100
chlorpheniraminemonochlorobenzenes;
pyridines;
tertiary amino compound
anti-allergic agent;
antidepressant;
antipruritic drug;
H1-receptor antagonist;
histamine antagonist;
serotonin uptake inhibitor
2008200816.0low000100
chlorpromazineorganochlorine compound;
phenothiazines;
tertiary amine
anticoronaviral agent;
antiemetic;
dopaminergic antagonist;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
phenothiazine antipsychotic drug
2008200816.0low000100
chlorpropamidemonochlorobenzenes;
N-sulfonylurea
hypoglycemic agent;
insulin secretagogue
2008200816.0low000100
chlorthalidoneisoindoles;
monochlorobenzenes;
sulfonamide
2008200816.0low000100
cifenlinediarylmethane2008200816.0low000100
cimetidinealiphatic sulfide;
guanidines;
imidazoles;
nitrile
adjuvant;
analgesic;
anti-ulcer drug;
H2-receptor antagonist;
P450 inhibitor
2008200816.0low000100
ciprofloxacinaminoquinoline;
cyclopropanes;
fluoroquinolone antibiotic;
N-arylpiperazine;
quinolinemonocarboxylic acid;
quinolone antibiotic;
quinolone;
zwitterion
antibacterial drug;
antiinfective agent;
antimicrobial agent;
DNA synthesis inhibitor;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
environmental contaminant;
topoisomerase IV inhibitor;
xenobiotic
2005200818.0low000300
citalopram2-benzofurans;
cyclic ether;
nitrile;
organofluorine compound;
tertiary amino compound
2005200818.0low000300
clomipraminedibenzoazepineanticoronaviral agent;
antidepressant;
EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor;
serotonergic antagonist;
serotonergic drug;
serotonin uptake inhibitor
2008200816.0low000100
clonazepam1,4-benzodiazepinone;
monochlorobenzenes
anticonvulsant;
anxiolytic drug;
GABA modulator
2005200818.0low000300
clonidineclonidine;
imidazoline
2008200816.0low000100
chlorazepate1,4-benzodiazepinoneanticonvulsant;
anxiolytic drug;
GABA modulator;
prodrug
2008200816.0medium000100
dapsonesubstituted aniline;
sulfone
anti-inflammatory drug;
antiinfective agent;
antimalarial;
leprostatic drug
2008200816.0low000100
desipraminedibenzoazepine;
secondary amino compound
adrenergic uptake inhibitor;
alpha-adrenergic antagonist;
antidepressant;
cholinergic antagonist;
drug allergen;
EC 3.1.4.12 (sphingomyelin phosphodiesterase) inhibitor;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
H1-receptor antagonist;
serotonin uptake inhibitor
2008200816.0low000100
nordazepam1,4-benzodiazepinone;
organochlorine compound
anticonvulsant;
anxiolytic drug;
GABA modulator;
human metabolite;
sedative
2008200816.0low000100
amphetamineprimary amine2008200816.0low000100
diazepam1,4-benzodiazepinone;
organochlorine compound
anticonvulsant;
anxiolytic drug;
environmental contaminant;
sedative;
xenobiotic
2008200816.0low000100
diazoxidebenzothiadiazine;
organochlorine compound;
sulfone
antihypertensive agent;
beta-adrenergic agonist;
bronchodilator agent;
cardiotonic drug;
diuretic;
K-ATP channel agonist;
sodium channel blocker;
sympathomimetic agent;
vasodilator agent
2008200816.0low000100
diclofenacamino acid;
aromatic amine;
dichlorobenzene;
monocarboxylic acid;
secondary amino compound
antipyretic;
drug allergen;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
environmental contaminant;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
xenobiotic
2005200817.5low000200
diflunisalmonohydroxybenzoic acid;
organofluorine compound
non-narcotic analgesic;
non-steroidal anti-inflammatory drug
2008200816.0low000100
diphenhydramineether;
tertiary amino compound
anti-allergic agent;
antidyskinesia agent;
antiemetic;
antiparkinson drug;
antipruritic drug;
antitussive;
H1-receptor antagonist;
local anaesthetic;
muscarinic antagonist;
oneirogen;
sedative
2008200816.0low000100
disopyramidemonocarboxylic acid amide;
pyridines;
tertiary amino compound
anti-arrhythmia drug2005200818.0low000300
valproic acidbranched-chain fatty acid;
branched-chain saturated fatty acid
anticonvulsant;
antimanic drug;
EC 3.5.1.98 (histone deacetylase) inhibitor;
GABA agent;
neuroprotective agent;
psychotropic drug;
teratogenic agent
2005200817.5low000200
domperidonebenzimidazoles;
heteroarylpiperidine
antiemetic;
dopaminergic antagonist
2008200816.0low000100
doxaprammorpholines;
pyrrolidin-2-ones
central nervous system stimulant2008200816.0low000100
doxazosinaromatic amine;
benzodioxine;
monocarboxylic acid amide;
N-acylpiperazine;
N-arylpiperazine;
quinazolines
alpha-adrenergic antagonist;
antihyperplasia drug;
antihypertensive agent;
antineoplastic agent;
vasodilator agent
2008200816.0low000100
doxepindibenzooxepine;
tertiary amino compound
antidepressant2008200816.0low000100
dyphyllineoxopurine;
propane-1,2-diols
bronchodilator agent;
EC 3.1.4.* (phosphoric diester hydrolase) inhibitor;
muscle relaxant;
vasodilator agent
2008200816.0low000100
enoxacin1,8-naphthyridine derivative;
amino acid;
fluoroquinolone antibiotic;
monocarboxylic acid;
N-arylpiperazine;
quinolone antibiotic
antibacterial drug;
DNA synthesis inhibitor
2008200816.0low000100
ethacrynic acidaromatic ether;
aromatic ketone;
dichlorobenzene;
monocarboxylic acid
EC 2.5.1.18 (glutathione transferase) inhibitor;
ion transport inhibitor;
loop diuretic
2008200816.0low000100
ethosuximidedicarboximide;
pyrrolidinone
anticonvulsant;
geroprotector;
T-type calcium channel blocker
2005200519.0low000200
etilefrinephenols2008200816.0low000100
felodipinedichlorobenzene;
dihydropyridine;
ethyl ester;
methyl ester
anti-arrhythmia drug;
antihypertensive agent;
calcium channel blocker;
vasodilator agent
2008200816.0low000100
berotekresorcinols;
secondary alcohol;
secondary amino compound
beta-adrenergic agonist;
bronchodilator agent;
sympathomimetic agent;
tocolytic agent
2008200816.0low000100
fenspirideazaspiro compound2008200816.0low000100
fentanylanilide;
monocarboxylic acid amide;
piperidines
adjuvant;
anaesthesia adjuvant;
anaesthetic;
intravenous anaesthetic;
mu-opioid receptor agonist;
opioid analgesic
2005200817.5low000200
flecainidearomatic ether;
monocarboxylic acid amide;
organofluorine compound;
piperidines
anti-arrhythmia drug2008200816.0low000100
fleroxacindifluorobenzene;
fluoroquinolone antibiotic;
monocarboxylic acid;
N-alkylpiperazine;
quinolines
antibacterial drug;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
topoisomerase IV inhibitor
2005200818.0low000300
fluconazoleconazole antifungal drug;
difluorobenzene;
tertiary alcohol;
triazole antifungal drug
environmental contaminant;
P450 inhibitor;
xenobiotic
2008200816.0low000100
flucytosineaminopyrimidine;
nucleoside analogue;
organofluorine compound;
pyrimidine antifungal drug;
pyrimidone
prodrug2008200816.0low000100
flumazenilethyl ester;
imidazobenzodiazepine;
organofluorine compound
antidote to benzodiazepine poisoning;
GABA antagonist
2008200816.0low000100
flunitrazepam1,4-benzodiazepinone;
C-nitro compound;
monofluorobenzenes
anxiolytic drug;
GABAA receptor agonist;
sedative
2008200816.0low000100
fluorescitebenzoic acids;
cyclic ketone;
hydroxy monocarboxylic acid;
organic heterotricyclic compound;
phenols;
xanthene dye
fluorescent dye;
radioopaque medium
2008200816.0low000100
fluorouracilnucleobase analogue;
organofluorine compound
antimetabolite;
antineoplastic agent;
environmental contaminant;
immunosuppressive agent;
radiosensitizing agent;
xenobiotic
2008200816.0low000100
flurbiprofenfluorobiphenyl;
monocarboxylic acid
antipyretic;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug
2005200519.0low000100
foscarnetcarboxylic acid;
one-carbon compound;
phosphonic acids
antiviral drug;
geroprotector;
HIV-1 reverse transcriptase inhibitor;
sodium-dependent Pi-transporter inhibitor
2008200816.0low000100
furosemidechlorobenzoic acid;
furans;
sulfonamide
environmental contaminant;
loop diuretic;
xenobiotic
2005200818.0low000300
gabapentingamma-amino acidanticonvulsant;
calcium channel blocker;
environmental contaminant;
xenobiotic
2005200818.0low000300
glimepiridesulfonamide2008200816.0low000100
glipizidearomatic amide;
monocarboxylic acid amide;
N-sulfonylurea;
pyrazines
EC 2.7.1.33 (pantothenate kinase) inhibitor;
hypoglycemic agent;
insulin secretagogue
2008200816.0low000100
glyburidemonochlorobenzenes;
N-sulfonylurea
anti-arrhythmia drug;
EC 2.7.1.33 (pantothenate kinase) inhibitor;
EC 3.6.3.49 (channel-conductance-controlling ATPase) inhibitor;
hypoglycemic agent
2008200816.0low000100
granisetronaromatic amide;
indazoles
2008200816.0low000100
guanfacineacetamides2008200816.0low000100
haloperidolaromatic ketone;
hydroxypiperidine;
monochlorobenzenes;
organofluorine compound;
tertiary alcohol
antidyskinesia agent;
antiemetic;
dopaminergic antagonist;
first generation antipsychotic;
serotonergic antagonist
2008200816.0low000100
hexobarbitalbarbiturates2008200816.0low000100
hydralazineazaarene;
hydrazines;
ortho-fused heteroarene;
phthalazines
antihypertensive agent;
vasodilator agent
2008200816.0low000100
hydroflumethiazidebenzothiadiazine;
thiazide
antihypertensive agent;
diuretic
2008200816.0low000100
hydroxychloroquineaminoquinoline;
organochlorine compound;
primary alcohol;
secondary amino compound;
tertiary amino compound
anticoronaviral agent;
antimalarial;
antirheumatic drug;
dermatologic drug
2008200816.0low000100
hydroxyureaone-carbon compound;
ureas
antimetabolite;
antimitotic;
antineoplastic agent;
DNA synthesis inhibitor;
EC 1.17.4.1 (ribonucleoside-diphosphate reductase) inhibitor;
genotoxin;
immunomodulator;
radical scavenger;
teratogenic agent
2008200816.0low000100
hypericin2008200816.0low000100
ibuprofenmonocarboxylic acidantipyretic;
cyclooxygenase 1 inhibitor;
cyclooxygenase 2 inhibitor;
drug allergen;
environmental contaminant;
geroprotector;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
radical scavenger;
xenobiotic
2008200816.0low000100
lidocainebenzenes;
monocarboxylic acid amide;
tertiary amino compound
anti-arrhythmia drug;
drug allergen;
environmental contaminant;
local anaesthetic;
xenobiotic
2005200818.0low000300
ifosfamideifosfamidesalkylating agent;
antineoplastic agent;
environmental contaminant;
immunosuppressive agent;
xenobiotic
2008200816.0low000100
imipraminedibenzoazepineadrenergic uptake inhibitor;
antidepressant;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor
2008200816.0low000100
amrinonebipyridinesEC 3.1.4.* (phosphoric diester hydrolase) inhibitor2008200816.0low000100
indomethacinaromatic ether;
indole-3-acetic acids;
monochlorobenzenes;
N-acylindole
analgesic;
drug metabolite;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
environmental contaminant;
gout suppressant;
non-steroidal anti-inflammatory drug;
xenobiotic metabolite;
xenobiotic
2005200818.0low000300
iohexolbenzenedicarboxamide;
organoiodine compound
environmental contaminant;
radioopaque medium;
xenobiotic
2008200816.0low000100
iopromidedicarboxylic acid diamide;
organoiodine compound
environmental contaminant;
nephrotoxic agent;
radioopaque medium;
xenobiotic
2008200816.0low000100
iothalamic acidorganic molecular entity2008200816.0low000100
avaproazaspiro compound;
biphenylyltetrazole
angiotensin receptor antagonist;
antihypertensive agent;
environmental contaminant;
xenobiotic
2008200816.0low000100
isoniazidcarbohydrazideantitubercular agent;
drug allergen
2008200816.0low000100
isoproterenolcatechols;
secondary alcohol;
secondary amino compound
beta-adrenergic agonist;
bronchodilator agent;
cardiotonic drug;
sympathomimetic agent
2008200816.0low000100
isradipinebenzoxadiazole;
dihydropyridine;
isopropyl ester;
methyl ester
2008200816.0low000100
itraconazolepiperazines2008200816.0low000100
ketaminecyclohexanones;
monochlorobenzenes;
secondary amino compound
analgesic;
environmental contaminant;
intravenous anaesthetic;
neurotoxin;
NMDA receptor antagonist;
xenobiotic
2008200816.0low000100
ketanserinaromatic ketone;
organofluorine compound;
piperidines;
quinazolines
alpha-adrenergic antagonist;
antihypertensive agent;
cardiovascular drug;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
serotonergic antagonist
2008200816.0low000100
ketoprofenbenzophenones;
oxo monocarboxylic acid
antipyretic;
drug allergen;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
environmental contaminant;
non-steroidal anti-inflammatory drug;
xenobiotic
2008200816.0low000100
ketorolacamino acid;
aromatic ketone;
monocarboxylic acid;
pyrrolizines;
racemate
analgesic;
cyclooxygenase 1 inhibitor;
cyclooxygenase 2 inhibitor;
non-steroidal anti-inflammatory drug
2005200818.0low000300
labetalolbenzamides;
benzenes;
phenols;
primary carboxamide;
salicylamides;
secondary alcohol;
secondary amino compound
2008200816.0low000100
lansoprazolebenzimidazoles;
pyridines;
sulfoxide
anti-ulcer drug;
EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor
2008200816.0low000100
letrozolenitrile;
triazoles
antineoplastic agent;
EC 1.14.14.14 (aromatase) inhibitor
2008200816.0low000100
lorazepambenzodiazepine2008200816.0low000100
losartanbiphenylyltetrazole;
imidazoles
angiotensin receptor antagonist;
anti-arrhythmia drug;
antihypertensive agent;
endothelin receptor antagonist
2008200816.0low000100
maprotilineanthracenes2008200816.0low000100
mebendazolearomatic ketone;
benzimidazoles;
carbamate ester
antinematodal drug;
microtubule-destabilising agent;
tubulin modulator
2008200816.0low000100
meperidineethyl ester;
piperidinecarboxylate ester;
tertiary amino compound
antispasmodic drug;
kappa-opioid receptor agonist;
mu-opioid receptor agonist;
opioid analgesic
2005200817.5low000200
mepivacainepiperidinecarboxamidedrug allergen;
local anaesthetic
2008200816.0low000100
meprobamateorganic molecular entity2008200816.0low000100
mesalamineamino acid;
aromatic amine;
monocarboxylic acid;
monohydroxybenzoic acid;
phenols
non-steroidal anti-inflammatory drug2008200816.0low000100
metforminguanidinesenvironmental contaminant;
geroprotector;
hypoglycemic agent;
xenobiotic
2008200816.0low000100
methadonebenzenes;
diarylmethane;
ketone;
tertiary amino compound
2008200816.0low000100
methapyrileneethylenediamine derivativeanti-allergic agent;
carcinogenic agent;
H1-receptor antagonist;
sedative
2008200816.0low000100
methylphenidatebeta-amino acid ester;
methyl ester;
piperidines
2008200816.0low000100
metoclopramidebenzamides;
monochlorobenzenes;
substituted aniline;
tertiary amino compound
antiemetic;
dopaminergic antagonist;
environmental contaminant;
gastrointestinal drug;
xenobiotic
2008200816.0low000100
metolazoneorganochlorine compound;
quinazolines;
sulfonamide
antihypertensive agent;
diuretic;
ion transport inhibitor
2008200816.0low000100
metoprololaromatic ether;
propanolamine;
secondary alcohol;
secondary amino compound
antihypertensive agent;
beta-adrenergic antagonist;
environmental contaminant;
geroprotector;
xenobiotic
2005200818.0low000300
metronidazoleC-nitro compound;
imidazoles;
primary alcohol
antiamoebic agent;
antibacterial drug;
antimicrobial agent;
antiparasitic agent;
antitrichomonal drug;
environmental contaminant;
prodrug;
radiosensitizing agent;
xenobiotic
2008200816.0low000100
mexiletinearomatic ether;
primary amino compound
anti-arrhythmia drug2008200816.0low000100
midazolamimidazobenzodiazepine;
monofluorobenzenes;
organochlorine compound
anticonvulsant;
antineoplastic agent;
anxiolytic drug;
apoptosis inducer;
central nervous system depressant;
GABAA receptor agonist;
general anaesthetic;
muscle relaxant;
sedative
2005200817.5low000200
milrinonebipyridines;
nitrile;
pyridone
cardiotonic drug;
EC 3.1.4.17 (3',5'-cyclic-nucleotide phosphodiesterase) inhibitor;
platelet aggregation inhibitor;
vasodilator agent
2008200816.0low000100
mirtazapinebenzazepine;
tetracyclic antidepressant
alpha-adrenergic antagonist;
anxiolytic drug;
H1-receptor antagonist;
histamine antagonist;
oneirogen;
serotonergic antagonist
2008200816.0low000100
mitoxantronedihydroxyanthraquinoneanalgesic;
antineoplastic agent
2008200816.0low000100
moclobemidebenzamides;
monochlorobenzenes;
morpholines
antidepressant;
environmental contaminant;
xenobiotic
2008200816.0low000100
acecainideacetamides;
benzamides
anti-arrhythmia drug2008200816.0low000100
naratriptanheteroarylpiperidine;
sulfonamide;
tryptamines
serotonergic agonist;
vasoconstrictor agent
2008200816.0low000100
nefazodonearomatic ether;
monochlorobenzenes;
N-alkylpiperazine;
N-arylpiperazine;
triazoles
alpha-adrenergic antagonist;
analgesic;
antidepressant;
serotonergic antagonist;
serotonin uptake inhibitor
2008200816.0low000100
nefopambenzoxazocine;
tertiary amino compound
2008200816.0low000100
nevirapinecyclopropanes;
dipyridodiazepine
antiviral drug;
HIV-1 reverse transcriptase inhibitor
2008200816.0low000100
nicardipinebenzenes;
C-nitro compound;
diester;
dihydropyridine;
methyl ester;
tertiary amino compound
2005200818.0low000300
nifedipineC-nitro compound;
dihydropyridine;
methyl ester
calcium channel blocker;
human metabolite;
tocolytic agent;
vasodilator agent
2008200816.0low000100
nimodipine2-methoxyethyl ester;
C-nitro compound;
dicarboxylic acids and O-substituted derivatives;
diester;
dihydropyridine;
isopropyl ester
antihypertensive agent;
calcium channel blocker;
cardiovascular drug;
vasodilator agent
2005200817.5low000200
nisoldipineC-nitro compound;
dicarboxylic acids and O-substituted derivatives;
diester;
dihydropyridine;
methyl ester
2005200817.5low000200
nitrazepam1,4-benzodiazepinone;
C-nitro compound
anticonvulsant;
antispasmodic drug;
drug metabolite;
GABA modulator;
sedative
2008200816.0low000100
nitrendipineC-nitro compound;
dicarboxylic acids and O-substituted derivatives;
diester;
dihydropyridine;
ethyl ester;
methyl ester
antihypertensive agent;
calcium channel blocker;
geroprotector;
vasodilator agent
2008200816.0low000100
nizatidine1,3-thiazoles;
C-nitro compound;
carboxamidine;
organic sulfide;
tertiary amino compound
anti-ulcer drug;
cholinergic drug;
H2-receptor antagonist
2008200816.0low000100
nomifensineisoquinolinesdopamine uptake inhibitor2008200816.0low000100
nortriptylineorganic tricyclic compound;
secondary amine
adrenergic uptake inhibitor;
analgesic;
antidepressant;
antineoplastic agent;
apoptosis inducer;
drug metabolite
2008200816.0low000100
ofloxacin3-oxo monocarboxylic acid;
N-arylpiperazine;
N-methylpiperazine;
organofluorine compound;
oxazinoquinoline
2005200817.5low000200
omeprazolearomatic ether;
benzimidazoles;
pyridines;
sulfoxide
2008200816.0low000100
ondansetroncarbazoles2008200816.0low000100
oxaprozin1,3-oxazoles;
monocarboxylic acid
analgesic;
non-steroidal anti-inflammatory drug
2005200519.0low000100
oxazepam1,4-benzodiazepinone;
organochlorine compound
anxiolytic drug;
environmental contaminant;
xenobiotic
2008200816.0low000100
oxiracetamorganonitrogen compound;
organooxygen compound
2008200816.0low000100
oxybutyninacetylenic compound;
carboxylic ester;
racemate;
tertiary alcohol;
tertiary amino compound
antispasmodic drug;
calcium channel blocker;
local anaesthetic;
muscarinic antagonist;
muscle relaxant;
parasympatholytic
2008200816.0low000100
pamidronatephosphonoacetic acid2008200816.0low000100
pantoprazolearomatic ether;
benzimidazoles;
organofluorine compound;
pyridines;
sulfoxide
anti-ulcer drug;
EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor;
environmental contaminant;
xenobiotic
2008200816.0low000100
papaverinebenzylisoquinoline alkaloid;
dimethoxybenzene;
isoquinolines
antispasmodic drug;
vasodilator agent
2008200816.0low000100
pentamidinearomatic ether;
carboxamidine;
diether
anti-inflammatory agent;
antifungal agent;
calmodulin antagonist;
chemokine receptor 5 antagonist;
EC 2.3.1.48 (histone acetyltransferase) inhibitor;
NMDA receptor antagonist;
S100 calcium-binding protein B inhibitor;
trypanocidal drug;
xenobiotic
2008200816.0low000100
pentobarbitalbarbituratesGABAA receptor agonist2008200816.0low000100
pentoxifyllineoxopurine2008200816.0low000100
perphenazineN-(2-hydroxyethyl)piperazine;
N-alkylpiperazine;
organochlorine compound;
phenothiazines
antiemetic;
dopaminergic antagonist;
phenothiazine antipsychotic drug
2008200816.0low000100
phenacetinacetamides;
aromatic ether
cyclooxygenase 3 inhibitor;
non-narcotic analgesic;
peripheral nervous system drug
2008200816.0low000100
phenobarbitalbarbituratesanticonvulsant;
drug allergen;
excitatory amino acid antagonist;
sedative
2008200816.0low000100
moxonidineorganohalogen compound;
pyrimidines
2008200816.0low000100
pimobendanbenzimidazoles;
pyridazinone
cardiotonic drug;
EC 3.1.4.* (phosphoric diester hydrolase) inhibitor;
vasodilator agent
2008200816.0low000100
pindololindoles;
secondary amine
antiglaucoma drug;
antihypertensive agent;
beta-adrenergic antagonist;
serotonergic antagonist;
vasodilator agent
2008200816.0low000100
piretanidearomatic ether2008200816.0low000100
prazosinaromatic ether;
furans;
monocarboxylic acid amide;
piperazines;
quinazolines
alpha-adrenergic antagonist;
antihypertensive agent;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor
2008200816.0low000100
prilocaineamino acid amide;
monocarboxylic acid amide
anticonvulsant;
local anaesthetic
2008200816.0low000100
primaquineaminoquinoline;
aromatic ether;
N-substituted diamine
antimalarial2008200816.0low000100
probenecidbenzoic acids;
sulfonamide
uricosuric drug2008200816.0low000100
procainamidebenzamidesanti-arrhythmia drug;
platelet aggregation inhibitor;
sodium channel blocker
2008200816.0low000100
prochlorperazineN-alkylpiperazine;
N-methylpiperazine;
organochlorine compound;
phenothiazines
alpha-adrenergic antagonist;
antiemetic;
cholinergic antagonist;
dopamine receptor D2 antagonist;
dopaminergic antagonist;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
first generation antipsychotic
2008200816.0low000100
procyclidinepyrrolidines;
tertiary alcohol
antidyskinesia agent;
antiparkinson drug;
muscarinic antagonist
2008200816.0low000100
promazinephenothiazines;
tertiary amine
antiemetic;
dopaminergic antagonist;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
H1-receptor antagonist;
muscarinic antagonist;
phenothiazine antipsychotic drug;
serotonergic antagonist
2008200816.0low000100
promethazinephenothiazines;
tertiary amine
anti-allergic agent;
anticoronaviral agent;
antiemetic;
antipruritic drug;
H1-receptor antagonist;
local anaesthetic;
sedative
2008200816.0low000100
propafenonearomatic ketone;
secondary alcohol;
secondary amino compound
anti-arrhythmia drug2008200816.0low000100
propofolphenolsanticonvulsant;
antiemetic;
intravenous anaesthetic;
radical scavenger;
sedative
2008200816.0low000100
propranololnaphthalenes;
propanolamine;
secondary amine
anti-arrhythmia drug;
antihypertensive agent;
anxiolytic drug;
beta-adrenergic antagonist;
environmental contaminant;
human blood serum metabolite;
vasodilator agent;
xenobiotic
2005200818.0low000300
pyridostigminepyridinium ion2008200816.0low000100
pyrimethamineaminopyrimidine;
monochlorobenzenes
antimalarial;
antiprotozoal drug;
EC 1.5.1.3 (dihydrofolate reductase) inhibitor
2008200816.0low000100
rabeprazolebenzimidazoles;
pyridines;
sulfoxide
anti-ulcer drug;
EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor
2008200816.0low000100
ranitidinearalkylamine2008200816.0low000100
risperidone1,2-benzoxazoles;
heteroarylpiperidine;
organofluorine compound;
pyridopyrimidine
alpha-adrenergic antagonist;
dopaminergic antagonist;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
H1-receptor antagonist;
psychotropic drug;
second generation antipsychotic;
serotonergic antagonist
2008200816.0low000100
rizatriptantryptaminesanti-inflammatory drug;
serotonergic agonist;
vasoconstrictor agent
2008200816.0low000100
sulfadiazinepyrimidines;
substituted aniline;
sulfonamide antibiotic;
sulfonamide
antiinfective agent;
antimicrobial agent;
antiprotozoal drug;
coccidiostat;
drug allergen;
EC 1.1.1.153 [sepiapterin reductase (L-erythro-7,8-dihydrobiopterin forming)] inhibitor;
EC 2.5.1.15 (dihydropteroate synthase) inhibitor;
environmental contaminant;
xenobiotic
2008200816.0low000100
risedronic acidpyridines2008200816.0low000100
sotalolethanolamines;
secondary alcohol;
secondary amino compound;
sulfonamide
anti-arrhythmia drug;
beta-adrenergic antagonist;
environmental contaminant;
xenobiotic
2008200816.0low000100
imatinibaromatic amine;
benzamides;
N-methylpiperazine;
pyridines;
pyrimidines
antineoplastic agent;
apoptosis inducer;
tyrosine kinase inhibitor
2008200816.0low000100
vorinostatdicarboxylic acid diamide;
hydroxamic acid
antineoplastic agent;
apoptosis inducer;
EC 3.5.1.98 (histone deacetylase) inhibitor
2008200816.0low000100
sulfamethoxazoleisoxazoles;
substituted aniline;
sulfonamide antibiotic;
sulfonamide
antibacterial agent;
antiinfective agent;
antimicrobial agent;
drug allergen;
EC 1.1.1.153 [sepiapterin reductase (L-erythro-7,8-dihydrobiopterin forming)] inhibitor;
EC 2.5.1.15 (dihydropteroate synthase) inhibitor;
environmental contaminant;
epitope;
P450 inhibitor;
xenobiotic
2008200816.0low000100
sulfinpyrazonepyrazolidines;
sulfoxide
uricosuric drug2008200816.0low000100
sulfisoxazoleisoxazoles;
sulfonamide antibiotic;
sulfonamide
antibacterial drug;
drug allergen
2008200816.0low000100
sumatriptansulfonamide;
tryptamines
serotonergic agonist;
vasoconstrictor agent
2008200816.0low000100
suprofenaromatic ketone;
monocarboxylic acid;
thiophenes
antirheumatic drug;
drug allergen;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
peripheral nervous system drug
2005200817.5low000200
suraminnaphthalenesulfonic acid;
phenylureas;
secondary carboxamide
angiogenesis inhibitor;
antinematodal drug;
antineoplastic agent;
apoptosis inhibitor;
EC 2.7.11.13 (protein kinase C) inhibitor;
GABA antagonist;
GABA-gated chloride channel antagonist;
purinergic receptor P2 antagonist;
ryanodine receptor agonist;
trypanocidal drug
2008200816.0low000100
gatifloxacinN-arylpiperazine;
organofluorine compound;
quinolinemonocarboxylic acid;
quinolone antibiotic;
quinolone
antiinfective agent;
antimicrobial agent;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor
2008200816.0low000100
temozolomideimidazotetrazine;
monocarboxylic acid amide;
triazene derivative
alkylating agent;
antineoplastic agent;
prodrug
2008200816.0low000100
terazosinfurans;
piperazines;
primary amino compound;
quinazolines
alpha-adrenergic antagonist;
antihypertensive agent;
antineoplastic agent
2008200816.0low000100
terbutalinephenylethanolamines;
resorcinols
anti-asthmatic drug;
beta-adrenergic agonist;
bronchodilator agent;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
hypoglycemic agent;
sympathomimetic agent;
tocolytic agent
2008200816.0low000100
thalidomidephthalimides;
piperidones
2008200816.0low000100
thiotepaaziridines2008200816.0low000100
tinidazoleimidazolesantiamoebic agent;
antibacterial drug;
antiparasitic agent;
antiprotozoal drug
2008200816.0low000100
tizanidinebenzothiadiazole;
imidazoles
alpha-adrenergic agonist;
muscle relaxant
2008200816.0low000100
tolbutamideN-sulfonylureahuman metabolite;
hypoglycemic agent;
insulin secretagogue;
potassium channel blocker
2008200816.0low000100
ultramaromatic ether;
tertiary alcohol;
tertiary amino compound
2008200816.0low000100
tranexamic acidamino acid2008200816.0low000100
trazodonemonochlorobenzenes;
N-alkylpiperazine;
N-arylpiperazine;
triazolopyridine
adrenergic antagonist;
antidepressant;
anxiolytic drug;
H1-receptor antagonist;
sedative;
serotonin uptake inhibitor
2008200816.0low000100
triamterenepteridinesdiuretic;
sodium channel blocker
2008200816.0low000100
triazolamtriazolobenzodiazepinesedative2008200816.0low000100
trimethadioneoxazolidinoneanticonvulsant;
geroprotector
2005200519.0low000100
trimethoprimaminopyrimidine;
methoxybenzenes
antibacterial drug;
diuretic;
drug allergen;
EC 1.5.1.3 (dihydrofolate reductase) inhibitor;
environmental contaminant;
xenobiotic
2008200816.0low000100
trimetrexate2008200816.0low000100
trimipraminedibenzoazepine;
tertiary amino compound
antidepressant;
environmental contaminant;
xenobiotic
2008200816.0low000100
troglitazonechromanes;
thiazolidinone
anticoagulant;
anticonvulsant;
antineoplastic agent;
antioxidant;
EC 6.2.1.3 (long-chain-fatty-acid--CoA ligase) inhibitor;
ferroptosis inhibitor;
hypoglycemic agent;
platelet aggregation inhibitor;
vasodilator agent
2005200519.0low000200
urapidilpiperazines2008200816.0low000100
venlafaxinecyclohexanols;
monomethoxybenzene;
tertiary alcohol;
tertiary amino compound
adrenergic uptake inhibitor;
analgesic;
antidepressant;
dopamine uptake inhibitor;
environmental contaminant;
serotonin uptake inhibitor;
xenobiotic
2005200817.5low000200
viloxazinearomatic ether2008200816.0low000100
zaleplonnitrile;
pyrazolopyrimidine
anticonvulsant;
anxiolytic drug;
central nervous system depressant;
sedative
2008200816.0low000100
zolpidemimidazopyridinecentral nervous system depressant;
GABA agonist;
sedative
2008200816.0low000100
zonisamide1,2-benzoxazoles;
sulfonamide
anticonvulsant;
antioxidant;
central nervous system drug;
protective agent;
T-type calcium channel blocker
2005200519.0low000100
zopiclonemonochloropyridine;
pyrrolopyrazine
central nervous system depressant;
sedative
2008200816.0low000100
prednisolone11beta-hydroxy steroid;
17alpha-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(1),Delta(4)-steroid;
C21-steroid;
glucocorticoid;
primary alpha-hydroxy ketone;
tertiary alpha-hydroxy ketone
adrenergic agent;
anti-inflammatory drug;
antineoplastic agent;
drug metabolite;
environmental contaminant;
immunosuppressive agent;
xenobiotic
2008200816.0low000100
cephaloridinebeta-lactam antibiotic allergen;
cephalosporin;
semisynthetic derivative
antibacterial drug2008200816.0low000100
prednisone11-oxo steroid;
17alpha-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(1),Delta(4)-steroid;
C21-steroid;
glucocorticoid;
primary alpha-hydroxy ketone;
tertiary alpha-hydroxy ketone
adrenergic agent;
anti-inflammatory drug;
antineoplastic agent;
immunosuppressive agent;
prodrug
2005200817.5low000200
penicillin gpenicillin allergen;
penicillin
antibacterial drug;
drug allergen;
epitope
2008200816.0low000100
chloramphenicolC-nitro compound;
carboxamide;
diol;
organochlorine compound
antibacterial drug;
antimicrobial agent;
Escherichia coli metabolite;
geroprotector;
Mycoplasma genitalium metabolite;
protein synthesis inhibitor
2008200816.0low000100
vincristineacetate ester;
formamides;
methyl ester;
organic heteropentacyclic compound;
organic heterotetracyclic compound;
tertiary alcohol;
tertiary amino compound;
vinca alkaloid
antineoplastic agent;
drug;
microtubule-destabilising agent;
plant metabolite;
tubulin modulator
2005200817.5low000200
ethinyl estradiol17-hydroxy steroid;
3-hydroxy steroid;
terminal acetylenic compound
xenoestrogen2005200818.0low000300
apomorphineaporphine alkaloidalpha-adrenergic drug;
antidyskinesia agent;
antiparkinson drug;
dopamine agonist;
emetic;
serotonergic drug
2008200816.0low000100
cephalothinazabicycloalkene;
beta-lactam antibiotic allergen;
carboxylic acid;
cephalosporin;
semisynthetic derivative;
thiophenes
antibacterial drug;
antimicrobial agent
2008200816.0low000100
kanamycin akanamycinsbacterial metabolite2008200816.0low000100
levodopaamino acid zwitterion;
dopa;
L-tyrosine derivative;
non-proteinogenic L-alpha-amino acid
allelochemical;
antidyskinesia agent;
antiparkinson drug;
dopaminergic agent;
hapten;
human metabolite;
mouse metabolite;
neurotoxin;
plant growth retardant;
plant metabolite;
prodrug
2005200817.5low000200
methicillinpenicillin allergen;
penicillin
antibacterial drug2008200816.0low000100
colchicinealkaloid;
colchicine
anti-inflammatory agent;
gout suppressant;
mutagen
2008200816.0low000100
oxacillinpenicillinantibacterial agent;
antibacterial drug
2008200816.0low000100
ampicillinbeta-lactam antibiotic;
penicillin allergen;
penicillin
antibacterial drug2008200816.0low000100
triamcinolone acetonide11beta-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(4) steroid;
cyclic ketal;
fluorinated steroid;
glucocorticoid;
primary alpha-hydroxy ketone
anti-allergic agent;
anti-inflammatory drug
2008200816.0low000100
phencyclidinebenzenes;
piperidines
anaesthetic;
neurotoxin;
NMDA receptor antagonist;
psychotropic drug
2005200817.5low000200
dichloroacetic acidmonocarboxylic acid;
organochlorine compound
astringent;
marine metabolite
2008200816.0low000100
methylprednisolone6-methylprednisolone;
primary alpha-hydroxy ketone;
tertiary alpha-hydroxy ketone
adrenergic agent;
anti-inflammatory drug;
antiemetic;
environmental contaminant;
neuroprotective agent;
xenobiotic
2008200816.0low000100
penicillin vpenicillin allergen;
penicillin
2008200816.0low000100
isosorbide dinitrateglucitol derivative;
nitrate ester
nitric oxide donor;
vasodilator agent
2005200817.5low000200
ergotaminepeptide ergot alkaloidalpha-adrenergic agonist;
mycotoxin;
non-narcotic analgesic;
oxytocic;
serotonergic agonist;
vasoconstrictor agent
2008200816.0low000100
neostigmine bromidebromide salt2008200816.0low000100
nafcillinpenicillin allergen;
penicillin
antibacterial drug2008200816.0low000100
methohexitalacetylenic compound;
barbiturates
drug allergen;
intravenous anaesthetic
2008200816.0low000100
pirinitramidenitrile2008200816.0low000100
edrophonium bromide2008200816.0medium000100
azacitidineN-glycosyl-1,3,5-triazine;
nucleoside analogue
antineoplastic agent2008200816.0low000100
galantaminebenzazepine alkaloid fundamental parent;
benzazepine alkaloid;
organic heterotetracyclic compound;
tertiary amino compound
antidote to curare poisoning;
cholinergic drug;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor;
plant metabolite
2008200816.0low000100
betamethasone11beta-hydroxy steroid;
17alpha-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(1),Delta(4)-steroid;
fluorinated steroid;
glucocorticoid;
primary alpha-hydroxy ketone;
tertiary alpha-hydroxy ketone
anti-asthmatic agent;
anti-inflammatory drug;
immunosuppressive agent
2008200816.0low000100
dextropropoxyphene1-benzyl-3-(dimethylamino)-2-methyl-1-phenylpropyl propanoatemu-opioid receptor agonist;
opioid analgesic
2008200816.0low000100
ketobemidonepiperidines2008200816.0low000100
chlormethiazolethiazoles2008200816.0low000100
methamphetamineamphetamines;
secondary amine
central nervous system stimulant;
environmental contaminant;
neurotoxin;
psychotropic drug;
xenobiotic
2008200816.0low000100
lithium carbonatecarbonate salt;
lithium salt
antimanic drug2008200816.0low000100
acetylcysteineacetylcysteine;
L-cysteine derivative;
N-acetyl-L-amino acid
antidote to paracetamol poisoning;
antiinfective agent;
antioxidant;
antiviral drug;
ferroptosis inhibitor;
geroprotector;
human metabolite;
mucolytic;
radical scavenger;
vulnerary
2008200816.0low000100
erythromycincyclic ketone;
erythromycin
2005200818.0low000300
levonorgestrel17beta-hydroxy steroid;
3-oxo-Delta(4) steroid;
terminal acetylenic compound
contraceptive drug;
female contraceptive drug;
progestin;
synthetic oral contraceptive
2008200816.0low000100
lormetazepam1,4-benzodiazepinone;
organochlorine compound
sedative2008200816.0low000100
vinblastine2005200817.5low000200
ethambutolethanolamines;
ethylenediamine derivative
antitubercular agent;
environmental contaminant;
xenobiotic
2008200816.0low000100
vancomycinglycopeptideantibacterial drug;
antimicrobial agent;
bacterial metabolite
2008200816.0low000100
metylperonaromatic ketone2008200816.0low000100
spectinomycincyclic acetal;
cyclic hemiketal;
cyclic ketone;
pyranobenzodioxin;
secondary alcohol;
secondary amino compound
antibacterial drug;
antimicrobial agent;
bacterial metabolite
2008200816.0low000100
dronabinolbenzochromene;
diterpenoid;
phytocannabinoid;
polyketide
cannabinoid receptor agonist;
epitope;
hallucinogen;
metabolite;
non-narcotic analgesic
2008200816.0low000100
benperidolaromatic ketone2008200816.0low000100
chlordesmethyldiazepambenzodiazepine2008200816.0low000100
stavudinedihydrofuran;
nucleoside analogue;
organic molecular entity
antimetabolite;
antiviral agent;
EC 2.7.7.49 (RNA-directed DNA polymerase) inhibitor
2008200816.0low000100
doxifluridineorganofluorine compound;
pyrimidine 5'-deoxyribonucleoside
antimetabolite;
antineoplastic agent;
prodrug
2008200816.0low000100
dicloxacillindichlorobenzene;
penicillin
antibacterial drug2008200816.0low000100
streptomycinantibiotic antifungal drug;
antibiotic fungicide;
streptomycins
antibacterial drug;
antifungal agrochemical;
antimicrobial agent;
antimicrobial drug;
bacterial metabolite;
protein synthesis inhibitor
2008200816.0low000100
cladribineorganochlorine compound;
purine 2'-deoxyribonucleoside
antineoplastic agent;
immunosuppressive agent
2008200816.0low000100
carbenicillinpenicillin allergen;
penicillin
antibacterial drug2008200816.0low000100
floxacillinpenicillin allergen;
penicillin
antibacterial drug2008200816.0low000100
beclomethasone dipropionate11beta-hydroxy steroid;
20-oxo steroid;
3-oxo-Delta(1),Delta(4)-steroid;
chlorinated steroid;
corticosteroid;
enone;
glucocorticoid;
propanoate ester;
steroid ester
anti-arrhythmia drug;
anti-asthmatic drug;
anti-inflammatory drug;
prodrug
2008200816.0low000100
olsalazineazobenzenes;
dicarboxylic acid
non-steroidal anti-inflammatory drug;
prodrug
2008200816.0low000100
terodilinediarylmethane2008200816.0low000100
1-(4-carboxyphenyl)-3,3-dimethyltriazene2008200816.0low000100
zalcitabinepyrimidine 2',3'-dideoxyribonucleosideantimetabolite;
antiviral drug;
HIV-1 reverse transcriptase inhibitor
2008200816.0low000100
metocurine iodidearomatic ether2008200816.0low000100
apazonebenzotriazinesnon-steroidal anti-inflammatory drug;
uricosuric drug
2008200816.0low000100
selegilineselegiline;
terminal acetylenic compound
geroprotector2008200816.0low000100
cephalexinbeta-lactam antibiotic allergen;
cephalosporin;
semisynthetic derivative
antibacterial drug2008200816.0low000100
isosorbide-5-mononitrateglucitol derivative;
nitrate ester
nitric oxide donor;
vasodilator agent
2005200817.5low000200
cephapirincephalosporinantibacterial drug2008200816.0low000100
pregnanolone3-hydroxy-5beta-pregnan-20-one;
3alpha-hydroxy steroid
human metabolite;
intravenous anaesthetic;
sedative
2008200816.0low000100
du-21220benzyl alcohols;
polyphenol;
secondary alcohol;
secondary amino compound
2008200816.0low000100
ribostamycinamino cyclitol glycoside;
aminoglycoside antibiotic
antibacterial drug;
antimicrobial agent;
metabolite
2008200816.0low000100
cefazolinbeta-lactam antibiotic allergen;
cephalosporin;
tetrazoles;
thiadiazoles
antibacterial drug2005200817.5low000200
halofenate2005200519.0low000100
amoxicillinpenicillin allergen;
penicillin
antibacterial drug2008200816.0low000100
timololtimololanti-arrhythmia drug;
antiglaucoma drug;
antihypertensive agent;
beta-adrenergic antagonist
2008200816.0low000100
indoramintryptamines2008200816.0low000100
toloxatoneoxazolidinone;
primary alcohol;
toluenes
2008200816.0low000100
zidovudineazide;
pyrimidine 2',3'-dideoxyribonucleoside
antimetabolite;
antiviral drug;
HIV-1 reverse transcriptase inhibitor
2005200817.5low000200
sisomicinamino cyclitol glycoside;
aminoglycoside antibiotic;
beta-L-arabinoside;
monosaccharide derivative
2008200816.0low000100
amdinocillinpenicillinantibacterial drug;
antiinfective agent
2008200816.0low000100
tobramycinamino cyclitol glycosideantibacterial agent;
antimicrobial agent;
toxin
2008200816.0low000100
paclitaxeltaxane diterpenoid;
tetracyclic diterpenoid
antineoplastic agent;
human metabolite;
metabolite;
microtubule-stabilising agent
2008200816.0low000100
etoposidebeta-D-glucoside;
furonaphthodioxole;
organic heterotetracyclic compound
antineoplastic agent;
DNA synthesis inhibitor
2008200816.0low000100
ticarcillinpenicillin allergen;
penicillin
antibacterial drug2008200816.0low000100
trimazosinN-arylpiperazine2008200816.0low000100
fenclorac2005200519.0medium000100
ribavirin1-ribosyltriazole;
aromatic amide;
monocarboxylic acid amide;
primary carboxamide
anticoronaviral agent;
antiinfective agent;
antimetabolite;
antiviral agent;
EC 2.7.7.49 (RNA-directed DNA polymerase) inhibitor
2008200816.0low000100
adinazolamtriazolobenzodiazepineanticonvulsant;
antidepressant;
anxiolytic drug;
sedative
2008200816.0low000100
amikacinalpha-D-glucoside;
amino cyclitol glycoside;
aminoglycoside;
carboxamide
antibacterial drug;
antimicrobial agent;
nephrotoxin
2008200816.0low000100
tolamolol2008200816.0low000100
cephradinebeta-lactam antibiotic allergen;
cephalosporin
antibacterial drug2008200816.0low000100
methyldopaL-tyrosine derivative;
non-proteinogenic L-alpha-amino acid
alpha-adrenergic agonist;
antihypertensive agent;
hapten;
peripheral nervous system drug;
sympatholytic agent
2008200816.0low000100
tocainidemonocarboxylic acid amideanti-arrhythmia drug;
local anaesthetic;
sodium channel blocker
2008200816.0low000100
sulbenicillinpenicillin2008200816.0low000100
sq-117252008200816.0low000100
diltiazem5-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl acetateantihypertensive agent;
calcium channel blocker;
vasodilator agent
2008200816.0low000100
vecuronium bromideorganic bromide salt;
quaternary ammonium salt
muscle relaxant;
neuromuscular agent;
nicotinic antagonist
2008200816.0low000100
meptazinolazepanes2008200816.0low000100
sufentanilanilide;
ether;
piperidines;
thiophenes
anaesthesia adjuvant;
intravenous anaesthetic;
mu-opioid receptor agonist;
opioid analgesic
2008200816.0low000100
torsemideaminopyridine;
N-sulfonylurea;
secondary amino compound
antihypertensive agent;
loop diuretic
2008200816.0low000100
medroxalolsalicylamides2008200816.0low000100
epirubicinaminoglycoside;
anthracycline antibiotic;
anthracycline;
deoxy hexoside;
monosaccharide derivative;
p-quinones;
primary alpha-hydroxy ketone;
tertiary alpha-hydroxy ketone
antimicrobial agent;
antineoplastic agent;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor
2008200816.0low000100
cefmetazolecephalosporinantibacterial drug2005200817.5low000200
lorcainideacetamides2008200816.0low000100
idarubicinanthracycline antibiotic;
deoxy hexoside;
monosaccharide derivative
2008200816.0low000100
ceforanidecephalosporinantibacterial drug2008200816.0low000100
piperacillinpenicillin allergen;
penicillin
antibacterial drug2008200816.0low000100
paroxetinearomatic ether;
benzodioxoles;
organofluorine compound;
piperidines
antidepressant;
anxiolytic drug;
hepatotoxic agent;
P450 inhibitor;
serotonin uptake inhibitor
2008200816.0low000100
captoprilalkanethiol;
L-proline derivative;
N-acylpyrrolidine;
pyrrolidinemonocarboxylic acid
antihypertensive agent;
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor
2005200817.5low000200
cefoperazonecephalosporinantibacterial drug2005200817.5low000200
atracuriumdiester;
quaternary ammonium ion
muscle relaxant;
nicotinic antagonist
2008200816.0low000100
moxalactamcephalosporin;
oxacephem
antibacterial drug2008200816.0low000100
endralazinebenzamides2008200816.0low000100
cefadroxil anhydrouscephalosporinantibacterial drug2008200816.0low000100
encainidebenzamides;
piperidines
anti-arrhythmia drug;
sodium channel blocker
2008200816.0low000100
pefloxacinfluoroquinolone antibiotic;
monocarboxylic acid;
N-alkylpiperazine;
N-arylpiperazine;
quinolone antibiotic;
quinolone
antibacterial drug;
antiinfective agent;
DNA synthesis inhibitor
2005200817.5low000200
alfentanilmonocarboxylic acid amide;
piperidines
central nervous system depressant;
intravenous anaesthetic;
mu-opioid receptor agonist;
opioid analgesic;
peripheral nervous system drug
2005200817.5low000200
miglustatpiperidines;
tertiary amino compound
anti-HIV agent;
EC 2.4.1.80 (ceramide glucosyltransferase) inhibitor
2005200519.0low000100
cefotetan2005200817.5low000200
recainam2005200818.0medium000300
lovastatindelta-lactone;
fatty acid ester;
hexahydronaphthalenes;
polyketide;
statin (naturally occurring)
anticholesteremic drug;
antineoplastic agent;
Aspergillus metabolite;
prodrug
2008200816.0low000100
flupirtineaminopyridine2008200816.0low000100
enoximonearomatic ketone2008200816.0low000100
idazoxanbenzodioxine;
imidazolines
alpha-adrenergic antagonist2008200816.0low000100
remoxipridedimethoxybenzene2008200816.0low000100
pravastatin3-hydroxy carboxylic acid;
carbobicyclic compound;
carboxylic ester;
hydroxy monocarboxylic acid;
secondary alcohol;
statin (semi-synthetic)
anticholesteremic drug;
environmental contaminant;
metabolite;
xenobiotic
2008200816.0low000100
bambuterolcarbamate ester;
phenylethanolamines
anti-asthmatic drug;
beta-adrenergic agonist;
bronchodilator agent;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
prodrug;
sympathomimetic agent;
tocolytic agent
2008200816.0low000100
atomoxetinearomatic ether;
secondary amino compound;
toluenes
adrenergic uptake inhibitor;
antidepressant;
environmental contaminant;
xenobiotic
2008200816.0low000100
amifloxacinquinolines2005200519.0low000100
trospectomycindioxanes2008200816.0low000100
finasteride3-oxo steroid;
aza-steroid;
delta-lactam
androgen antagonist;
antihyperplasia drug;
EC 1.3.1.22 [3-oxo-5alpha-steroid 4-dehydrogenase (NADP(+))] inhibitor
2008200816.0low000100
sematilide2008200816.0low000100
esmololaromatic ether;
ethanolamines;
methyl ester;
secondary alcohol;
secondary amino compound
2008200816.0low000100
clinafloxacinquinolines2008200816.0low000100
adefovir6-aminopurines;
ether;
phosphonic acids
antiviral drug;
DNA synthesis inhibitor;
drug metabolite;
HIV-1 reverse transcriptase inhibitor;
nephrotoxic agent
2008200816.0low000100
loxiglumideorganic molecular entity2008200816.0low000100
sparfloxacinfluoroquinolone antibiotic;
N-arylpiperazine;
quinolinemonocarboxylic acid;
quinolone antibiotic;
quinolone
2008200816.0low000100
tebufelone2005200519.0low000100
cidofovir anhydrousphosphonic acids;
pyrimidone
anti-HIV agent;
antineoplastic agent;
antiviral drug;
photosensitizing agent
2008200816.0low000100
tiagabinebeta-amino acid;
piperidinemonocarboxylic acid;
tertiary amino compound;
thiophenes
anticonvulsant;
GABA reuptake inhibitor
2008200816.0low000100
mibefradiltetralinsT-type calcium channel blocker2008200816.0low000100
topotecanpyranoindolizinoquinolineantineoplastic agent;
EC 5.99.1.2 (DNA topoisomerase) inhibitor
2008200816.0low000100
bromfenacaromatic amino acid;
benzophenones;
organobromine compound;
substituted aniline
non-narcotic analgesic;
non-steroidal anti-inflammatory drug
2008200816.0low000100
gemcitabineorganofluorine compound;
pyrimidine 2'-deoxyribonucleoside
antimetabolite;
antineoplastic agent;
antiviral drug;
DNA synthesis inhibitor;
EC 1.17.4.1 (ribonucleoside-diphosphate reductase) inhibitor;
environmental contaminant;
immunosuppressive agent;
photosensitizing agent;
prodrug;
radiosensitizing agent;
xenobiotic
2008200816.0low000100
ibutilidebenzenes;
organic amino compound
2008200816.0low000100
aripiprazolearomatic ether;
delta-lactam;
dichlorobenzene;
N-alkylpiperazine;
N-arylpiperazine;
quinolone
drug metabolite;
H1-receptor antagonist;
second generation antipsychotic;
serotonergic agonist
2008200816.0low000100
remifentanilalpha-amino acid ester;
anilide;
monocarboxylic acid amide;
piperidinecarboxylate ester
intravenous anaesthetic;
mu-opioid receptor agonist;
opioid analgesic;
sedative
2008200816.0low000100
lamivudinemonothioacetal;
nucleoside analogue;
oxacycle;
primary alcohol
allergen;
anti-HBV agent;
antiviral drug;
EC 2.7.7.49 (RNA-directed DNA polymerase) inhibitor;
HIV-1 reverse transcriptase inhibitor;
prodrug
2005200817.5low000200
irinotecancarbamate ester;
delta-lactone;
N-acylpiperidine;
pyranoindolizinoquinoline;
ring assembly;
tertiary alcohol;
tertiary amino compound
antineoplastic agent;
apoptosis inducer;
EC 5.99.1.2 (DNA topoisomerase) inhibitor;
prodrug
2005200817.5low000200
valsartanbiphenylyltetrazole;
monocarboxylic acid amide;
monocarboxylic acid
angiotensin receptor antagonist;
antihypertensive agent;
environmental contaminant;
xenobiotic
2008200816.0low000100
ibandronic acid2008200816.0low000100
ziprasidone1,2-benzisothiazole;
indolones;
organochlorine compound;
piperazines
antipsychotic agent;
dopaminergic antagonist;
histamine antagonist;
muscarinic antagonist;
psychotropic drug;
serotonergic antagonist
2008200816.0low000100
zanamivirguanidinesantiviral agent;
EC 3.2.1.18 (exo-alpha-sialidase) inhibitor
2008200816.0low000100
zolmitriptanoxazolidinone;
tryptamines
anti-inflammatory drug;
serotonergic agonist;
vasoconstrictor agent
2008200816.0low000100
tiludronic acidorganochlorine compound2005200519.0low000200
tirofibanL-tyrosine derivative;
piperidines;
sulfonamide
anticoagulant;
fibrin modulating drug;
platelet glycoprotein-IIb/IIIa receptor antagonist
2008200816.0low000100
cisatracuriumdiester;
quaternary ammonium ion
muscle relaxant;
nicotinic antagonist
2008200816.0low000100
fosinoprilatL-proline derivative;
phosphinic acids
antihypertensive agent;
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor
2008200816.0low000100
trovafloxacin2005200818.0low000300
cefprozilcephalosporin;
semisynthetic derivative
antibacterial drug2008200816.0medium000100
iopamidolbenzenedicarboxamide;
organoiodine compound;
pentol
environmental contaminant;
radioopaque medium;
xenobiotic
2008200816.0low000100
imipramine n-oxidedibenzooxazepine2008200816.0low000100
ritipenem2005200519.0low000100
flomoxefN-acyl-amino acid;
organonitrogen heterocyclic antibiotic;
oxacephem
antibacterial drug2005200519.0low000100
dexloxiglumideglutamic acid derivative2008200816.0low000100
intoplicinepyridoindole2008200816.0low000100
repaglinidepiperidines2008200816.0low000100
telmisartanbenzimidazoles;
biphenyls;
carboxybiphenyl
angiotensin receptor antagonist;
antihypertensive agent;
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor;
environmental contaminant;
xenobiotic
2008200816.0low000100
inogatran2005200519.0low000100
dexfenfluraminefenfluramineappetite depressant;
serotonergic agonist;
serotonin uptake inhibitor
2005200817.5low000200
ethinyl estradiol-17-sulfate2008200816.0medium000100
ethinylestradiol-3-sulfate17beta-hydroxy steroid;
steroid sulfate
antineoplastic agent;
estrogen
2008200816.0low000100
cefcanel2008200816.0medium000100
zoledronic acid1,1-bis(phosphonic acid);
imidazoles
bone density conservation agent2008200816.0low000100
epristeridesteroid acid2008200816.0low000100
talinololureas2008200816.0low000100
flunoxaprofen1,3-benzoxazoles;
monocarboxylic acid;
organofluorine compound
antirheumatic drug;
hepatotoxic agent;
non-steroidal anti-inflammatory drug;
protein kinase C agonist
2005200519.0low000100
denaverinediarylmethane2008200816.0low000100
diprafenonearomatic compound2008200816.0low000100
nebivololchromanes;
diol;
organofluorine compound;
secondary alcohol;
secondary amino compound
2008200816.0medium000100
uk 68798aromatic ether;
sulfonamide;
tertiary amino compound
anti-arrhythmia drug;
potassium channel blocker
2008200816.0low000100
ljc 10627carbapenems;
organic sulfide;
pyrazolotriazole
antibacterial drug2005200817.5low000200
dexrazoxanerazoxaneantineoplastic agent;
cardiovascular drug;
chelator;
immunosuppressive agent
2008200816.0low000100
voriconazoleconazole antifungal drug;
difluorobenzene;
pyrimidines;
tertiary alcohol;
triazole antifungal drug
P450 inhibitor2008200816.0low000100
betamipronorganonitrogen compound;
organooxygen compound
2005200817.5low000200
bufuralolbenzofurans2008200816.0low000100
panipenemorganic molecular entity2005200817.5low000200
perindoprilatdicarboxylic acid;
dipeptide;
L-alanine derivative;
organic heterobicyclic compound
antihypertensive agent;
drug metabolite;
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor
2008200816.0low000100
7-hydroxystaurosporine2008200816.0low000100
methotrimeprazinephenothiazines;
tertiary amine
anticoronaviral agent;
cholinergic antagonist;
dopaminergic antagonist;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
non-narcotic analgesic;
phenothiazine antipsychotic drug;
serotonergic antagonist
2008200816.0low000100
9-aminocamptothecinpyranoindolizinoquinoline2008200816.0low000100
sch 343432005200817.5low000200
squalaminebile acid2008200816.0low000100
atovaquonehydroxy-1,2-naphthoquinone2008200816.0low000100
rivastigminecarbamate ester;
tertiary amino compound
cholinergic drug;
EC 3.1.1.8 (cholinesterase) inhibitor;
neuroprotective agent
2008200816.0low000100
frovatriptancarbazoles2008200816.0low000100
eletriptanindoles;
N-alkylpyrrolidine;
sulfone
non-steroidal anti-inflammatory drug;
serotonergic agonist;
vasoconstrictor agent
2008200816.0low000100
rosiglitazoneaminopyridine;
thiazolidinediones
EC 6.2.1.3 (long-chain-fatty-acid--CoA ligase) inhibitor;
ferroptosis inhibitor;
insulin-sensitizing drug
2008200816.0low000100
flunisolide11beta-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(1),Delta(4)-steroid;
cyclic ketal;
fluorinated steroid;
primary alpha-hydroxy ketone
anti-asthmatic drug;
anti-inflammatory drug;
immunosuppressive agent
2005200519.0low000200
clarithromycinmacrolide antibioticantibacterial drug;
environmental contaminant;
protein synthesis inhibitor;
xenobiotic
2008200816.0low000100
nicotine3-(1-methylpyrrolidin-2-yl)pyridineanxiolytic drug;
biomarker;
immunomodulator;
mitogen;
neurotoxin;
nicotinic acetylcholine receptor agonist;
peripheral nervous system drug;
phytogenic insecticide;
plant metabolite;
psychotropic drug;
teratogenic agent;
xenobiotic
2005200817.5low000200
mci 9038peptide2008200816.0low000100
imipenem, anhydrousbeta-lactam antibiotic allergen;
carbapenems;
zwitterion
antibacterial drug2008200816.0low000100
bosentan anhydrousprimary alcohol;
pyrimidines;
sulfonamide
antihypertensive agent;
endothelin receptor antagonist
2008200816.0low000100
asulacrineacridines2008200816.0low000100
hydroxycotinineN-alkylpyrrolidine;
pyridines;
pyrrolidin-2-ones;
pyrrolidine alkaloid
2008200816.0low000100
quinaprilatdicarboxylic acid;
isoquinolines;
tertiary carboxamide
antihypertensive agent;
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor;
vasodilator agent
2008200816.0low000100
2-hydroxyimipraminedibenzoazepine2008200816.0low000100
ecteinascidin 743acetate ester;
azaspiro compound;
bridged compound;
hemiaminal;
isoquinoline alkaloid;
lactone;
organic heteropolycyclic compound;
organic sulfide;
oxaspiro compound;
polyphenol;
tertiary amino compound
alkylating agent;
angiogenesis modulating agent;
anti-inflammatory agent;
antineoplastic agent;
marine metabolite
2008200816.0low000100
almotriptanindoles;
sulfonamide;
tertiary amine
non-steroidal anti-inflammatory drug;
serotonergic agonist;
vasoconstrictor agent
2008200816.0low000100
mk 0663bipyridines;
organochlorine compound;
sulfone
cyclooxygenase 2 inhibitor;
non-steroidal anti-inflammatory drug
2008200816.0low000100
gefitinibaromatic ether;
monochlorobenzenes;
monofluorobenzenes;
morpholines;
quinazolines;
secondary amino compound;
tertiary amino compound
antineoplastic agent;
epidermal growth factor receptor antagonist
2008200816.0low000100
methotrexatedicarboxylic acid;
monocarboxylic acid amide;
pteridines
abortifacient;
antimetabolite;
antineoplastic agent;
antirheumatic drug;
dermatologic drug;
DNA synthesis inhibitor;
EC 1.5.1.3 (dihydrofolate reductase) inhibitor;
immunosuppressive agent
2005200817.5low000200
1,2,3,6-tetrahydro-4-phenyl-1-((3-phenyl-3-cyclohexen-1-yl)methyl)pyridine2005200519.0low000100
tamsulosin5-(2-{[2-(2-ethoxyphenoxy)ethyl]amino}propyl)-2-methoxybenzenesulfonamidealpha-adrenergic antagonist;
antineoplastic agent
2008200816.0low000100
sulbactampenicillanic acids2008200816.0low000100
dilevalol2-hydroxy-5-{1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl}benzamide2008200816.0medium000100
docetaxelhydrate;
secondary alpha-hydroxy ketone
antineoplastic agent2008200816.0low000100
irofulvencyclohexenones2008200816.0low000100
ym 8722008200816.0low000100
levofloxacin9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid;
fluoroquinolone antibiotic;
quinolone antibiotic
antibacterial drug;
DNA synthesis inhibitor;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
topoisomerase IV inhibitor
2008200816.0low000100
ertapenemcarbapenemcarboxylic acid;
pyrrolidinecarboxamide
antibacterial drug2008200816.0low000100
dx 8951pyranoindolizinoquinoline2008200816.0low000100
cilomilastmethoxybenzenes2008200816.0low000100
conivaptanbenzazepineaquaretic;
vasopressin receptor antagonist
2008200816.0low000100
tezosentan2008200816.0low000100
sabarubicin2008200816.0low000100
moxifloxacinaromatic ether;
cyclopropanes;
fluoroquinolone antibiotic;
pyrrolidinopiperidine;
quinolinemonocarboxylic acid;
quinolone antibiotic;
quinolone
antibacterial drug2005200818.0low000300
clevidipinedihydropyridine2008200816.0low000100
solifenacinisoquinolines2008200816.0low000100
xamoterolmorpholines2008200816.0low000100
naproxenmethoxynaphthalene;
monocarboxylic acid
antipyretic;
cyclooxygenase 1 inhibitor;
cyclooxygenase 2 inhibitor;
drug allergen;
environmental contaminant;
gout suppressant;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
xenobiotic
2005200519.0low000100
abanoquil2008200816.0low000100
anidulafunginantibiotic antifungal drug;
azamacrocycle;
echinocandin;
heterodetic cyclic peptide;
semisynthetic derivative
2008200816.0low000100
atropine2008200816.0low000100
ropivacainepiperidinecarboxamide;
ropivacaine
local anaesthetic2008200816.0low000100
melagatranazetidines;
carboxamidine;
dicarboxylic acid monoamide;
non-proteinogenic alpha-amino acid;
secondary amino compound
anticoagulant;
EC 3.4.21.5 (thrombin) inhibitor;
serine protease inhibitor
2008200816.0low000100
ezlopitant2005200519.0low000100
tesaglitazar2008200816.0low000100
bms2043522008200816.0low000100
fosfluconazoleconazole antifungal drug;
triazole antifungal drug;
triazoles
prodrug2008200816.0low000100
cp 101,6062008200816.0low000100
nsc-89199carbamate ester;
organochlorine compound;
steroid phosphate
2008200816.0medium000100
phenethicillinpenicillin allergen;
penicillin
2008200816.0low000100
acivicinisoxazoles;
non-proteinogenic L-alpha-amino acid;
organochlorine compound
antileishmanial agent;
antimetabolite;
antimicrobial agent;
antineoplastic agent;
EC 2.3.2.2 (gamma-glutamyltransferase) inhibitor;
glutamine antagonist;
metabolite
2005200817.5low000200
bortezomibamino acid amide;
L-phenylalanine derivative;
pyrazines
antineoplastic agent;
antiprotozoal drug;
protease inhibitor;
proteasome inhibitor
2008200816.0low000100
ritonavir1,3-thiazoles;
carbamate ester;
carboxamide;
L-valine derivative;
ureas
antiviral drug;
environmental contaminant;
HIV protease inhibitor;
xenobiotic
2005200519.0low000100
quinidinecinchona alkaloidalpha-adrenergic antagonist;
anti-arrhythmia drug;
antimalarial;
drug allergen;
EC 1.14.13.181 (13-deoxydaunorubicin hydroxylase) inhibitor;
EC 3.6.3.44 (xenobiotic-transporting ATPase) inhibitor;
muscarinic antagonist;
P450 inhibitor;
potassium channel blocker;
sodium channel blocker
2005200817.5low000200
meropenemalpha,beta-unsaturated monocarboxylic acid;
carbapenemcarboxylic acid;
organic sulfide;
pyrrolidinecarboxamide
antibacterial agent;
antibacterial drug;
drug allergen
2005200817.5low000200
cefoxitinbeta-lactam antibiotic allergen;
cephalosporin;
cephamycin;
semisynthetic derivative
antibacterial drug2008200816.0low000100
digitoxincardenolide glycosideEC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor2008200816.0low000100
moxalactam disodium2005200519.0low000100
saquinavirL-asparagine derivative;
quinolines
antiviral drug;
HIV protease inhibitor
2008200816.0low000100
pancuroniumacetate ester;
steroid ester
cholinergic antagonist;
muscle relaxant;
nicotinic antagonist
2008200816.0low000100
rocuronium3alpha-hydroxy steroid;
acetate ester;
androstane;
morpholines;
quaternary ammonium ion;
tertiary amino compound
drug allergen;
muscle relaxant;
neuromuscular agent
2008200816.0low000100
abacavir2,6-diaminopurinesantiviral drug;
drug allergen;
HIV-1 reverse transcriptase inhibitor
2008200816.0low000100
netilmicin2008200816.0low000100
miglitolpiperidines2008200816.0low000100
linezolidacetamides;
morpholines;
organofluorine compound;
oxazolidinone
antibacterial drug;
protein synthesis inhibitor
2008200816.0low000100
tolterodinetertiary amineantispasmodic drug;
muscarinic antagonist;
muscle relaxant
2008200816.0low000100
darifenacin1-benzofurans;
monocarboxylic acid amide;
pyrrolidines
antispasmodic drug;
muscarinic antagonist
2008200816.0low000100
fluticasone propionate11beta-hydroxy steroid;
3-oxo-Delta(1),Delta(4)-steroid;
corticosteroid;
fluorinated steroid;
propanoate ester;
steroid ester;
thioester
adrenergic agent;
anti-allergic agent;
anti-asthmatic drug;
anti-inflammatory drug;
bronchodilator agent;
dermatologic drug
2008200816.0low000100
acarboseamino cyclitol;
glycoside
2008200816.0low000100
tacrolimusmacrolide lactambacterial metabolite;
immunosuppressive agent
2008200816.0low000100
cerivastatindihydroxy monocarboxylic acid;
pyridines;
statin (synthetic)
2008200816.0low000100
rosuvastatindihydroxy monocarboxylic acid;
monofluorobenzenes;
pyrimidines;
statin (synthetic);
sulfonamide
anti-inflammatory agent;
antilipemic drug;
cardioprotective agent;
CETP inhibitor;
environmental contaminant;
xenobiotic
2008200816.0low000100
cocainebenzoate ester;
methyl ester;
tertiary amino compound;
tropane alkaloid
adrenergic uptake inhibitor;
central nervous system stimulant;
dopamine uptake inhibitor;
environmental contaminant;
local anaesthetic;
mouse metabolite;
plant metabolite;
serotonin uptake inhibitor;
sodium channel blocker;
sympathomimetic agent;
vasoconstrictor agent;
xenobiotic
2005200817.5low000200
clindamycin2008200816.0low000100
fosfomycinepoxide;
phosphonic acids
antimicrobial agent;
EC 2.5.1.7 (UDP-N-acetylglucosamine 1-carboxyvinyltransferase) inhibitor
2008200816.0low000100
zithromaxmacrolide antibioticantibacterial drug;
environmental contaminant;
xenobiotic
2005200817.5low000200
bms 214662benzenes;
benzodiazepine;
imidazoles;
nitrile;
sulfonamide;
thiophenes
antineoplastic agent;
apoptosis inducer;
EC 2.5.1.58 (protein farnesyltransferase) inhibitor
2008200816.0low000100
eptifibatidehomodetic cyclic peptide;
macrocycle;
organic disulfide
anticoagulant;
platelet aggregation inhibitor
2008200816.0low000100
gs 4071acetate ester;
amino acid;
cyclohexenecarboxylic acid;
primary amino compound
antiviral drug;
EC 3.2.1.18 (exo-alpha-sialidase) inhibitor;
marine xenobiotic metabolite
2008200816.0low000100
decitabine2'-deoxyribonucleoside2008200816.0low000100
sm 86682008200816.0low000100
teniposidearomatic ether;
beta-D-glucoside;
cyclic acetal;
furonaphthodioxole;
gamma-lactone;
monosaccharide derivative;
phenols;
thiophenes
antineoplastic agent;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor
2008200816.0low000100
troxacitabinecarbohydrate derivative;
nucleobase-containing molecular entity
2008200816.0low000100
cefamandolecephalosporin;
semisynthetic derivative
antibacterial drug2008200816.0low000100
tiazofurin1,3-thiazoles;
C-glycosyl compound;
monocarboxylic acid amide
antineoplastic agent;
EC 1.1.1.205 (IMP dehydrogenase) inhibitor;
prodrug
2005200817.5low000200
melphalanL-phenylalanine derivative;
nitrogen mustard;
non-proteinogenic L-alpha-amino acid;
organochlorine compound
alkylating agent;
antineoplastic agent;
carcinogenic agent;
drug allergen;
immunosuppressive agent
2008200816.0low000100
sitafloxacinfluoroquinolone antibiotic;
quinolines;
quinolone antibiotic
2008200816.0low000100
tenofovirnucleoside analogue;
phosphonic acids
antiviral drug;
drug metabolite;
HIV-1 reverse transcriptase inhibitor
2008200816.0low000100
dibekacinkanamycinsantibacterial agent;
protein synthesis inhibitor
2008200816.0low000100
micafunginantibiotic antifungal drug;
echinocandin
antiinfective agent2008200816.0low000100
cefpiramidecarboxylic acid;
cephalosporin
antibacterial drug2005200519.0low000100
mezlocillinpenicillin allergen;
penicillin
antibacterial drug2008200816.0low000100
tropisetronindolyl carboxylic acid2008200816.0low000100
leuprolideoligopeptideanti-estrogen;
antineoplastic agent;
gonadotropin releasing hormone agonist
2008200816.0low000100
fludarabinepurine nucleoside2008200816.0low000100
propylthiouracilpyrimidinethioneantidote to paracetamol poisoning;
antimetabolite;
antioxidant;
antithyroid drug;
carcinogenic agent;
EC 1.14.13.39 (nitric oxide synthase) inhibitor;
hormone antagonist
2008200816.0low000100
etomidateethyl ester;
imidazoles
intravenous anaesthetic;
sedative
2008200816.0low000100
mercaptopurinearyl thiol;
purines;
thiocarbonyl compound
anticoronaviral agent;
antimetabolite;
antineoplastic agent
2008200816.0low000100
cotinineN-alkylpyrrolidine;
pyridines;
pyrrolidin-2-ones;
pyrrolidine alkaloid
antidepressant;
biomarker;
human xenobiotic metabolite;
plant metabolite
2008200816.0low000100
methimazole1,3-dihydroimidazole-2-thionesantithyroid drug2008200816.0low000100
drotaverinisoquinolines2008200816.0low000100
digoxincardenolide glycoside;
steroid saponin
anti-arrhythmia drug;
cardiotonic drug;
EC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor;
epitope
2008200816.0low000100
cancidas2008200816.0low000100
lincomycincarbohydrate-containing antibiotic;
L-proline derivative;
monocarboxylic acid amide;
pyrrolidinecarboxamide;
S-glycosyl compound
antimicrobial agent;
bacterial metabolite
2008200816.0low000100
thiopentalbarbituratesanticonvulsant;
drug allergen;
environmental contaminant;
intravenous anaesthetic;
sedative;
xenobiotic
2008200816.0low000100
hmr 36472008200816.0low000100
nelarabinebeta-D-arabinoside;
monosaccharide derivative;
purine nucleoside
antineoplastic agent;
DNA synthesis inhibitor;
prodrug
2008200816.0low000100
2-[(2-ethoxyphenoxy)-phenylmethyl]morpholinearomatic ether2008200816.0low000100
dolasetronindolyl carboxylic acid2008200816.0low000100
or 1259hydrazone;
nitrile;
pyridazinone
anti-arrhythmia drug;
cardiotonic drug;
EC 3.1.4.17 (3',5'-cyclic-nucleotide phosphodiesterase) inhibitor;
vasodilator agent
2008200816.0low000100
gestodenesteroidestrogen2008200816.0low000100
quininecinchona alkaloidantimalarial;
muscle relaxant;
non-narcotic analgesic
2008200816.0low000100
isepamicin2008200816.0low000100
lamifibanN-acylglycine2005200817.5low000200
telavancinglycopeptideantibacterial drug;
antimicrobial agent
2008200816.0low000100
susalimod2005200519.0high000100
sitagliptintriazolopyrazine;
trifluorobenzene
EC 3.4.14.5 (dipeptidyl-peptidase IV) inhibitor;
environmental contaminant;
hypoglycemic agent;
serine proteinase inhibitor;
xenobiotic
2008200816.0low000100
tolcapone2-nitrophenols;
benzophenones;
catechols
antiparkinson drug;
EC 2.1.1.6 (catechol O-methyltransferase) inhibitor
2008200816.0low000100
quercetin7-hydroxyflavonol;
pentahydroxyflavone
antibacterial agent;
antineoplastic agent;
antioxidant;
Aurora kinase inhibitor;
chelator;
EC 1.10.99.2 [ribosyldihydronicotinamide dehydrogenase (quinone)] inhibitor;
geroprotector;
phytoestrogen;
plant metabolite;
protein kinase inhibitor;
radical scavenger
2008200816.0low000100
amphotericin bantibiotic antifungal drug;
macrolide antibiotic;
polyene antibiotic
antiamoebic agent;
antiprotozoal drug;
bacterial metabolite
2005200519.0low000100
clavulanic acidoxapenamantibacterial drug;
anxiolytic drug;
bacterial metabolite;
EC 3.5.2.6 (beta-lactamase) inhibitor
2008200816.0low000100
pulmicort11beta-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(1),Delta(4)-steroid;
cyclic acetal;
glucocorticoid;
primary alpha-hydroxy ketone
anti-inflammatory drug;
bronchodilator agent;
drug allergen
2008200816.0low000100
eprosartandicarboxylic acid;
imidazoles;
thiophenes
angiotensin receptor antagonist;
antihypertensive agent;
environmental contaminant;
xenobiotic
2008200816.0low000100
montelukastaliphatic sulfide;
monocarboxylic acid;
quinolines
anti-arrhythmia drug;
anti-asthmatic drug;
leukotriene antagonist
2008200816.0low000100
mivacuriumisoquinolines2008200816.0low000100
entacapone2-nitrophenols;
catechols;
monocarboxylic acid amide;
nitrile
antidyskinesia agent;
antiparkinson drug;
central nervous system drug;
EC 2.1.1.6 (catechol O-methyltransferase) inhibitor
2008200816.0low000100
paricalcitolhydroxy seco-steroid;
seco-cholestane
antiparathyroid drug2008200816.0low000100
sdz psc 833homodetic cyclic peptide2008200816.0low000100
l 660,711quinolines2005200519.0low000100
indocyanine green1,1-diunsubstituted alkanesulfonate;
benzoindole;
cyanine dye
2008200816.0medium000100
codeinemorphinane alkaloid;
organic heteropentacyclic compound
antitussive;
drug allergen;
environmental contaminant;
opioid analgesic;
opioid receptor agonist;
prodrug;
xenobiotic
2008200816.0low000100
cyclosporinehomodetic cyclic peptideanti-asthmatic drug;
anticoronaviral agent;
antifungal agent;
antirheumatic drug;
carcinogenic agent;
dermatologic drug;
EC 3.1.3.16 (phosphoprotein phosphatase) inhibitor;
geroprotector;
immunosuppressive agent;
metabolite
2008200816.0low000100
hydromorphonemorphinane alkaloid;
organic heteropentacyclic compound
mu-opioid receptor agonist;
opioid analgesic
2008200816.0low000100
nalmefenemorphinane alkaloid2008200816.0low000100
naloxonemorphinane alkaloid;
organic heteropentacyclic compound;
tertiary alcohol
antidote to opioid poisoning;
central nervous system depressant;
mu-opioid receptor antagonist
2008200816.0low000100
oxycodoneorganic heteropentacyclic compound;
semisynthetic derivative
antitussive;
mu-opioid receptor agonist;
opioid analgesic
2008200816.0low000100
alvocidibdihydroxyflavone;
hydroxypiperidine;
monochlorobenzenes;
tertiary amino compound
antineoplastic agent;
antirheumatic drug;
apoptosis inducer;
EC 2.7.11.22 (cyclin-dependent kinase) inhibitor
2008200816.0low000100
morphinemorphinane alkaloid;
organic heteropentacyclic compound;
tertiary amino compound
anaesthetic;
drug allergen;
environmental contaminant;
geroprotector;
mu-opioid receptor agonist;
opioid analgesic;
plant metabolite;
vasodilator agent;
xenobiotic
2005200817.5low000200
cicaprostmonoterpenoid2008200816.0low000100
dexmedetomidinemedetomidinealpha-adrenergic agonist;
analgesic;
non-narcotic analgesic;
sedative
2008200816.0low000100
iloprostcarbobicyclic compound;
monocarboxylic acid;
secondary alcohol
platelet aggregation inhibitor;
vasodilator agent
2005200817.5low000200
nalbuphineorganic heteropentacyclic compoundmu-opioid receptor antagonist;
opioid analgesic
2008200816.0low000100
nateglinidephenylalanine derivative2008200816.0low000100
vinorelbineacetate ester;
methyl ester;
organic heteropentacyclic compound;
organic heterotetracyclic compound;
ring assembly;
vinca alkaloid
antineoplastic agent;
photosensitizing agent
2008200816.0low000100
romidepsincyclodepsipeptide;
heterocyclic antibiotic;
organic disulfide
antineoplastic agent;
EC 3.5.1.98 (histone deacetylase) inhibitor
2008200816.0low000100
(6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic aciddihydroxy monocarboxylic acid;
indoles;
organofluorine compound
2005200818.0low000300
naltrexonecyclopropanes;
morphinane-like compound;
organic heteropentacyclic compound
antidote to opioid poisoning;
central nervous system depressant;
environmental contaminant;
mu-opioid receptor antagonist;
xenobiotic
2005200817.5low000200
morphine-6-glucuronidemorphinane alkaloid2008200816.0low000100
butorphanolmorphinane alkaloidantitussive;
kappa-opioid receptor agonist;
mu-opioid receptor agonist;
opioid analgesic
2008200816.0low000100
cefodizime1,3-thiazoles;
cephalosporin;
oxime O-ether
antibacterial drug;
EC 1.14.18.1 (tyrosinase) inhibitor
2005200817.5low000200
methylnaltrexonephenanthrenes2008200816.0low000100
cefiximecephalosporinantibacterial drug;
drug allergen
2008200816.0low000100
lisinoprildipeptideEC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor2008200816.0low000100
indinavir sulfatedicarboxylic acid diamide;
N-(2-hydroxyethyl)piperazine;
piperazinecarboxamide
HIV protease inhibitor2005200817.5low000200
enalaprilat anhydrousdicarboxylic acid;
dipeptide
antihypertensive agent;
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor
2008200816.0low000100
cefuroxime3-(carbamoyloxymethyl)cephalosporin;
furans;
oxime O-ether
drug allergen2008200816.0low000100
ceftriaxone1,2,4-triazines;
1,3-thiazoles;
cephalosporin;
oxime O-ether
antibacterial drug;
drug allergen;
EC 3.5.2.6 (beta-lactamase) inhibitor
2005200817.5low000200
cefepimecephalosporin;
oxime O-ether
antibacterial drug2005200817.5low000200
hr 810cephalosporin;
cyclopentapyridine
2008200816.0low000100
ceftazidimecephalosporin;
oxime O-ether
antibacterial drug;
drug allergen;
EC 2.4.1.129 (peptidoglycan glycosyltransferase) inhibitor
2008200816.0low000100
cefetametcephalosporin2008200816.0low000100
famotidine1,3-thiazoles;
guanidines;
sulfonamide
anti-ulcer drug;
H2-receptor antagonist;
P450 inhibitor
2008200816.0low000100
cefotaxime1,3-thiazoles;
cephalosporin;
oxime O-ether
antibacterial drug;
drug allergen
2008200816.0low000100
aztreonambeta-lactam antibiotic allergen;
monobactam
antibacterial drug;
drug allergen;
EC 2.4.1.129 (peptidoglycan glycosyltransferase) inhibitor
2005200817.5low000200
ginkgolide b2008200816.0low000100
ro 42-5892cyclopropanes;
diol;
L-histidine derivative;
secondary carboxamide;
sulfone
antihypertensive agent;
EC 3.4.23.15 (renin) inhibitor;
peptidomimetic;
vasodilator agent
2005200519.0low000200
palonosetronazabicycloalkane;
delta-lactam;
organic heterotricyclic compound
antiemetic;
serotonergic antagonist
2008200816.0low000100
cefatrizineamino acid amide;
carboxylic acid;
cephalosporin;
phenols;
semisynthetic derivative;
triazoles
antibacterial drug;
EC 2.7.11.20 (elongation factor 2 kinase) inhibitor
2008200816.0low000100
eniporide2008200816.0low000100
cilastatincarboxamide;
L-cysteine derivative;
non-proteinogenic L-alpha-amino acid;
organic sulfide
EC 3.4.13.19 (membrane dipeptidase) inhibitor;
environmental contaminant;
protease inhibitor;
xenobiotic
2008200816.0low000100
ixabepilone1,3-thiazoles;
beta-hydroxy ketone;
epoxide;
lactam;
macrocycle
antineoplastic agent;
microtubule-destabilising agent
2008200816.0low000100
gavestinel2005200519.0medium000100
azlocillinpenicillin allergen;
penicillin;
semisynthetic derivative
antibacterial drug2008200816.0low000100
verlukast2008200816.0low000100
ceftizoximecephalosporinantibacterial drug2005200817.5low000200
cefclidincephalosporin;
thiadiazoles
2005200519.0low000100
carumonammonobactamantibacterial drug2008200816.0low000100
nitrofurantoinimidazolidine-2,4-dione;
nitrofuran antibiotic;
organonitrogen heterocyclic antibiotic;
organooxygen heterocyclic antibiotic
antibacterial drug;
antiinfective agent;
hepatotoxic agent
2008200816.0low000100
eritoranlipid As2008200816.0low000100
dantrolene2008200816.0low000100
artesunateartemisinin derivative;
cyclic acetal;
dicarboxylic acid monoester;
hemisuccinate;
semisynthetic derivative;
sesquiterpenoid
antimalarial;
antineoplastic agent;
ferroptosis inducer
2008200816.0low000100
dexniguldipinediarylmethane2008200816.0low000100
napsagatran2005200817.5low000200
temsirolimusmacrolide lactam2008200816.0low000100
ganaxolonecorticosteroid hormone2005200519.0low000100
bms1887972008200816.0medium000100
azimilideimidazolidine-2,4-dione2008200816.0low000100
cefozoprancephalosporin;
imidazopyridazine;
thiadiazoles
2005200519.0medium000100
tomopenem2008200816.0low000100
bb-836982008200816.0medium000100
sb 2422352005200519.0low000100
zotarolimuslactam;
macrolide
2008200816.0low000100
gentamicin sulfate2008200816.0low000100
bn 520202008200816.0low000100
vindesine2008200816.0low000100
moxestrol3-hydroxy steroid2005200519.0low000100
scopolamine hydrobromide2008200816.0low000100
bisaramil2008200816.0low000100
teicoplanin2008200816.0high000100
ly-146032heterodetic cyclic peptide;
lipopeptide antibiotic;
lipopeptide;
macrocycle;
macrolide
antibacterial drug;
bacterial metabolite;
calcium-dependent antibiotics
2008200816.0low000100
dalbavancincarbohydrate acid derivative;
glycopeptide;
monosaccharide derivative;
semisynthetic derivative
antibacterial drug;
antimicrobial agent
2008200816.0medium000100
cetrorelixoligopeptideantineoplastic agent;
GnRH antagonist
2008200816.0low000100
tetracycline2008200816.0low000100
chlortetracycline2008200816.0low000100
oxytetracycline, anhydrous2008200816.0low000100
minocycline2008200816.0low000100
roquinimexaromatic amide2008200816.0low000100
mobic1,3-thiazoles;
benzothiazine;
monocarboxylic acid amide
analgesic;
antirheumatic drug;
cyclooxygenase 2 inhibitor;
non-steroidal anti-inflammatory drug
2005200817.5low000200
mobiflexheteroaryl hydroxy compound;
monocarboxylic acid amide;
pyridines;
thienothiazine
antipyretic;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug
2008200816.0low000100
isoxicambenzothiazine;
isoxazoles;
monocarboxylic acid amide
antirheumatic drug;
non-steroidal anti-inflammatory drug
2008200816.0low000100
warfarinbenzenes;
hydroxycoumarin;
methyl ketone
2005200817.5low000200
demeclocycline2008200816.0low000100
rolitetracycline2008200816.0low000100
sudoxicam2005200519.0medium000200
tigecycline2008200816.0low000100
acyclovir2-aminopurines;
oxopurine
antimetabolite;
antiviral drug
2005200817.5low000200
rifampincyclic ketal;
hydrazone;
N-iminopiperazine;
N-methylpiperazine;
rifamycins;
semisynthetic derivative;
zwitterion
angiogenesis inhibitor;
antiamoebic agent;
antineoplastic agent;
antitubercular agent;
DNA synthesis inhibitor;
EC 2.7.7.6 (RNA polymerase) inhibitor;
Escherichia coli metabolite;
geroprotector;
leprostatic drug;
neuroprotective agent;
pregnane X receptor agonist;
protein synthesis inhibitor
2008200816.0low000100
clozapinebenzodiazepine;
N-arylpiperazine;
N-methylpiperazine;
organochlorine compound
adrenergic antagonist;
dopaminergic antagonist;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
environmental contaminant;
GABA antagonist;
histamine antagonist;
muscarinic antagonist;
second generation antipsychotic;
serotonergic antagonist;
xenobiotic
2008200816.0low000100
dacarbazinedacarbazine2008200816.0low000100
didanosinepurine 2',3'-dideoxyribonucleosideantimetabolite;
antiviral drug;
EC 2.4.2.1 (purine-nucleoside phosphorylase) inhibitor;
geroprotector;
HIV-1 reverse transcriptase inhibitor
2005200817.5low000200
ganciclovir2-aminopurines;
oxopurine
antiinfective agent;
antiviral drug
2008200816.0low000100
sildenafilpiperazines;
pyrazolopyrimidine;
sulfonamide
EC 3.1.4.35 (3',5'-cyclic-GMP phosphodiesterase) inhibitor;
vasodilator agent
2008200816.0low000100
penciclovir2-aminopurines;
propane-1,3-diols
antiviral drug2008200816.0low000100
vardenafilimidazotriazine;
N-alkylpiperazine;
N-sulfonylpiperazine
EC 3.1.4.* (phosphoric diester hydrolase) inhibitor;
vasodilator agent
2008200816.0low000100
allopurinolnucleobase analogue;
organic heterobicyclic compound
antimetabolite;
EC 1.17.3.2 (xanthine oxidase) inhibitor;
gout suppressant;
radical scavenger
2008200816.0low000100
leucovorinformyltetrahydrofolic acidEscherichia coli metabolite;
mouse metabolite
2008200816.0low000100
tegaserodcarboxamidine;
guanidines;
hydrazines;
indoles
gastrointestinal drug;
serotonergic agonist
2008200816.0low000100
tirapazaminearomatic amine;
benzotriazines;
N-oxide
antibacterial agent;
antineoplastic agent;
apoptosis inducer
2008200816.0low000100
pelrinone2005200519.0medium000200
aprepitant(trifluoromethyl)benzenes;
cyclic acetal;
morpholines;
triazoles
antidepressant;
antiemetic;
neurokinin-1 receptor antagonist;
peripheral nervous system drug;
substance P receptor antagonist
2008200816.0low000100
ceftobiprolecephalosporin;
thiadiazoles
antimicrobial agent2008200816.0low000100
rifabutin2008200816.0low000100
SubstanceStudiesClassesRolesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
glycerolalditol;
triol
algal metabolite;
detergent;
Escherichia coli metabolite;
geroprotector;
human metabolite;
mouse metabolite;
osmolyte;
Saccharomyces cerevisiae metabolite;
solvent
1994199430.0low001000
4-aminopyridineaminopyridine;
aromatic amine
avicide;
orphan drug;
potassium channel blocker
1998199826.0low001000
aspirinbenzoic acids;
phenyl acetates;
salicylates
anticoagulant;
antipyretic;
cyclooxygenase 1 inhibitor;
cyclooxygenase 2 inhibitor;
drug allergen;
EC 1.1.1.188 (prostaglandin-F synthase) inhibitor;
geroprotector;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
plant activator;
platelet aggregation inhibitor;
prostaglandin antagonist;
teratogenic agent
1993202324.5low109011
dipyridamolepiperidines;
pyrimidopyrimidine;
tertiary amino compound;
tetrol
adenosine phosphodiesterase inhibitor;
EC 3.5.4.4 (adenosine deaminase) inhibitor;
platelet aggregation inhibitor;
vasodilator agent
1993199331.0low001000
furegrelatebenzofurans2003200321.0low000100
glyburidemonochlorobenzenes;
N-sulfonylurea
anti-arrhythmia drug;
EC 2.7.1.33 (pantothenate kinase) inhibitor;
EC 3.6.3.49 (channel-conductance-controlling ATPase) inhibitor;
hypoglycemic agent
1994199430.0low001000
hexamethoniumquaternary ammonium salt1997199727.0low001000
indomethacinaromatic ether;
indole-3-acetic acids;
monochlorobenzenes;
N-acylindole
analgesic;
drug metabolite;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
environmental contaminant;
gout suppressant;
non-steroidal anti-inflammatory drug;
xenobiotic metabolite;
xenobiotic
1997199727.0low001000
losartanbiphenylyltetrazole;
imidazoles
angiotensin receptor antagonist;
anti-arrhythmia drug;
antihypertensive agent;
endothelin receptor antagonist
1996199628.0low001000
prazosinaromatic ether;
furans;
monocarboxylic acid amide;
piperazines;
quinazolines
alpha-adrenergic antagonist;
antihypertensive agent;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor
1997199727.0low001000
tetraethylammoniumquaternary ammonium ion1998199826.0low001000
ticlopidinemonochlorobenzenes;
thienopyridine
anticoagulant;
fibrin modulating drug;
hematologic agent;
P2Y12 receptor antagonist;
platelet aggregation inhibitor
1993199331.0low001000
phenylephrinephenols;
phenylethanolamines;
secondary amino compound
alpha-adrenergic agonist;
cardiotonic drug;
mydriatic agent;
nasal decongestant;
protective agent;
sympathomimetic agent;
vasoconstrictor agent
2001200123.0low000100
pyrrolespyrrole;
secondary amine
2001200123.0low000100
thiophenesmancude organic heteromonocyclic parent;
monocyclic heteroarene;
thiophenes;
volatile organic compound
non-polar solvent201520159.0low000010
n-heptanealkane;
volatile organic compound
non-polar solvent;
plant metabolite
1993199331.0low001000
oxazoles1,3-oxazoles;
mancude organic heteromonocyclic parent;
monocyclic heteroarene
1992201925.6low3030730
hydrazineazane;
hydrazines
EC 4.3.1.10 (serine-sulfate ammonia-lyase) inhibitor1993199630.0low003000
ng-nitroarginine methyl esteralpha-amino acid ester;
L-arginine derivative;
methyl ester;
N-nitro compound
EC 1.14.13.39 (nitric oxide synthase) inhibitor1998200323.5low001100
bm 135052003200321.0low000100
atorvastatinaromatic amide;
dihydroxy monocarboxylic acid;
monofluorobenzenes;
pyrroles;
statin (synthetic)
environmental contaminant;
xenobiotic
2001200123.0low000100
web 2086organonitrogen heterocyclic compound;
organosulfur heterocyclic compound
1993199928.0low002000
triazoles1,2,3-triazole1993199928.0low002000
masoprocolnordihydroguaiaretic acidantineoplastic agent;
hypoglycemic agent;
lipoxygenase inhibitor;
metabolite
1999199925.0low001000
cremophor el1994199430.0low001000
1-hexadecyl-2-acetyl-glycero-3-phosphocholine2-acetyl-1-alkyl-sn-glycero-3-phosphocholineantihypertensive agent;
beta-adrenergic antagonist;
bronchoconstrictor agent;
hematologic agent;
vasodilator agent
1999201517.0low001010
thromboxanes202320231.0low000001
phenylalanyl-prolyl-arginine-chloromethyl ketone1993199331.0low001000
3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid2013201311.0low000010
pd 1450652002200222.0low000100
angiotensin iiamino acid zwitterion;
angiotensin II
human metabolite2002200421.0low000200
benzofurans2003200321.0low000100
fibrinpeptide1996199628.0low001000
nitroarginineguanidines;
L-arginine derivative;
N-nitro compound;
non-proteinogenic L-alpha-amino acid
2004200420.0low000100
arachidonic acidicosa-5,8,11,14-tetraenoic acid;
long-chain fatty acid;
omega-6 fatty acid
Daphnia galeata metabolite;
EC 3.1.1.1 (carboxylesterase) inhibitor;
human metabolite;
mouse metabolite
1995199927.0low002000
prostaglandin h2olefinic compound;
oxylipin;
prostaglandins H;
secondary alcohol
mouse metabolite2001200123.0low000100
prostaglandin d2prostaglandins Dhuman metabolite;
mouse metabolite
2003200321.0low000100
ricinoleic acid(9Z)-12-hydroxyoctadec-9-enoic acid1994199430.0low001000
sc 560aromatic ether;
monochlorobenzenes;
organofluorine compound;
pyrazoles
angiogenesis modulating agent;
antineoplastic agent;
apoptosis inducer;
cyclooxygenase 1 inhibitor;
non-steroidal anti-inflammatory drug
2004200420.0low000100
dinoprostoneprostaglandins Ehuman metabolite;
mouse metabolite;
oxytocic
1993202316.0low001001
dinoprostmonocarboxylic acid;
prostaglandins Falpha
human metabolite;
mouse metabolite
1996199628.0low001000
thromboxane a2epoxy monocarboxylic acid;
thromboxanes A
mouse metabolite1992201525.0low008310
8,11,14-eicosatrienoic acidfatty acid 20:3;
long-chain fatty acid
fungal metabolite;
human metabolite;
nutraceutical
2004200420.0low000100
leukotriene e4amino dicarboxylic acid;
L-cysteine thioether;
leukotriene;
non-proteinogenic L-alpha-amino acid;
secondary alcohol
202320231.0low000001
8-epi-prostaglandin f2alphaF2-isoprostanebiomarker;
bronchoconstrictor agent;
vasoconstrictor agent
1996199628.0low001000
thromboxane b2thromboxanes Bhuman metabolite;
mouse metabolite
1993200326.3low002100
sq 307411992199232.0low001000
sq 295481993199630.0low003000
15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid1992200427.7low006100
enalaprildicarboxylic acid monoester;
dipeptide
antihypertensive agent;
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor;
geroprotector;
prodrug
1999199925.0low101000
7-(3-(3-hydroxy-4-(4'-iodophenoxy)-1-butenyl)-7-oxabicyclo(2.2.1)heptan-2-yl)-5-heptenoic acid1993199331.0low001000
vapiprost1993199331.0low001000
prasugrel hydrochloride201520159.0low000010
endothelin-12002200421.0low000200
warfarinbenzenes;
hydroxycoumarin;
methyl ketone
1993199331.0low001000
transforming growth factor beta1997199727.0low001000
transforming growth factor alpha1997199727.0low001000
cyclosporine1994199430.0low001000
ConditionIndicatedStudiesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
Alcoholic Fatty Liver01997201319.0low001010
Alcoholic Liver Diseases01997199727.0low001000
Alloxan Diabetes02002200222.0low000100
Angina Pectoris01994199430.0low001000
Angor Pectoris01994199430.0low001000
Anti-Phospholipid Antibody Syndrome01994199430.0low001000
Antiphospholipid Syndrome01994199430.0low001000
Aortic Coarctation01997199727.0low001000
Apoplexy02001200123.0low000100
Arteriosclerosis02003200321.0low000100
Aspirin Induced Asthma0201520235.0low000011
Bacterial Infections, Gram-Negative01999199925.0low001000
Becker Muscular Dystrophy0201920195.0low000010
Blood Clot01993200127.8low003100
Blood Pressure, High01995200226.0low005200
Brain Vascular Disorders01996199628.0low001000
Cardiac Diseases01999199925.0low001000
Cardiac Failure01999199925.0low101000
Cardiomyopathies0201920195.0low000010
Cardiomyopathies, Primary0201920195.0low000010
Cardiovascular Stroke01995199529.0low001000
Carotid Arteriopathies, Traumatic01996199628.0low001000
Carotid Artery Thrombosis01993199331.0low002000
Cerebrovascular Disorders01996199628.0low001000
Cirrhosis02013201311.0low000010
Coarctation of Aorta01997199727.0low001000
Disease Models, Animal01993201924.5low004110
Elevated Cholesterol02001200322.0low000200
Endotoxin Shock01999199925.0low001000
Fetal Resorption01994199430.0low001000
Fibrosis02013201311.0low000010
Focal Segmental Glomerulosclerosis02001200123.0low000100
Genetic Predisposition01996199628.0low001000
Glomerulosclerosis, Focal Segmental02001200123.0low000100
Goldblatt Syndrome01996199628.0low001000
Graft Occlusion, Vascular01997199727.0low001000
Gram-Negative Bacterial Infections01999199925.0low001000
Heart Disease, Ischemic01994200128.0low003100
Heart Diseases01999199925.0low001000
Heart Failure01999199925.0low101000
Hypercholesterolemia02001200322.0low000200
Hyperlipemia02003200321.0low000100
Hyperlipidemias02003200321.0low000100
Hypertension01995200226.0low005200
Hypertension, Pulmonary01999199925.0low001000
Hypertension, Renovascular01996199628.0low001000
Hypertriglyceridemia02003200321.0low000100
Injuries01997199727.0low001000
Injury, Myocardial Reperfusion01994199529.7low003000
Ischemia01997199727.0low001000
Leg Ulcer01997199727.0low001000
Liver Diseases, Alcoholic01997199727.0low001000
Muscle Contraction01993200127.0low001100
Muscular Dystrophy, Duchenne1201920195.0low000010
Myocardial Infarction01995199529.0low001000
Myocardial Ischemia01994200128.0low003100
Pregnancy01994199430.0low001000
Pulmonary Hypertension01999199925.0low001000
Shock, Septic01999199925.0low001000
Sinus Infections0202320231.0low000001
Sinusitis0202320231.0low000001
Stasis Ulcer01998199826.0low101000
Stroke02001200123.0low000100
Thrombosis01993200127.8low003100
Varicose Ulcer01998199826.0low101000
Wounds and Injuries01997199727.0low001000

Long-term Use (1)

ArticleYear
Effect of ifetroban, a thromboxane A2 receptor antagonist, in stroke-prone spontaneously hypertensive rats.
Clinical and experimental hypertension (New York, N.Y. : 1993), , Volume: 18, Issue:2
1996

Pharmacokinetics (3)

ArticleYear
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Drug metabolism and disposition: the biological fate of chemicals, , Volume: 36, Issue:7
2008
Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure.
Journal of pharmaceutical sciences, , Volume: 94, Issue:7
2005
Inhibition of prostaglandin D2 clearance in rat hepatocytes by the thromboxane receptor antagonists daltroban and ifetroban and the thromboxane synthase inhibitor furegrelate.
Biochemical pharmacology, , Aug-15, Volume: 66, Issue:4
2003

Bioavailability (1)

ArticleYear
Disposition of radiolabeled ifetroban in rats, dogs, monkeys, and humans.
Drug metabolism and disposition: the biological fate of chemicals, , Volume: 28, Issue:8
2000

Dosage (2)

ArticleYear
Atorvastatin prevents glomerulosclerosis and renal endothelial dysfunction in hypercholesterolaemic rabbits.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, , Volume: 16 Suppl 1
2001
Antiplatelet activity of the long-acting thromboxane receptor antagonist BMS 180,291 in monkeys.
Prostaglandins, , Volume: 44, Issue:5
1992